SlideShare a Scribd company logo

The Annual G20 Scorecard – Research Performance 2019

B
bhavesh lande

The 2019 G20 Scorecard analyzes the research performance of G20 nations, detailing their output, citation impacts, and collaboration trends while highlighting key metrics such as gender balance and open access publication rates. It identifies that the G20 collectively contributes over 70% of global research output, with a focus on enhancing international cooperation as a driver of economic and innovative advancement. The report provides nuanced country-specific profiles for policymakers to track research progress without ranking them, emphasizing the variability in research maturity among member states.

Education
1 of 27
Download to read offline
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
The Annual G20 Scorecard – Research Performance 2019 Professor Jonathan Adams, Gordon Rogers & Dr Martin Szomszor
1 Professor Jonathan Adams is Director at the Institute for Scientific Information, at the Web of Science Group. He is also a Visiting Professor at King’s College London, Policy Institute, and was awarded an Honorary D.Sc. in 2017 by the University of Exeter, for his work in higher education and research policy. Dr. Martin Szomszor is Head of Research Analytics at the Institute for Scientific Information. He joined from Digital Science, where, as Chief Data Scientist he applied his extensive knowledge of machine learning, data integration and visualization techniques to found the Global Research Identifier Database. He was named a 2015 top-50 UK Information Age data leader for his work in creating the REF2015 impact case studies database for the Higher Education Funding Council for England (HEFCE). Gordon Rogers is a Senior Data Scientist at the Institute for Scientific Information. He has worked in the fields of bibliometrics and data analysis for the past 10 years, supporting clients around the world in evaluating their research portfolio and strategy. Author biographies About the Web of Science Group The Web of Science Group organizes the world’s research information to enable academia, corporations, publishers and governments accelerate the pace of research. It is powered by the Web of Science – the world’s largest publisher-neutral citation index and research intelligence platform. Its many well-known brands also include Converis, EndNote, Kopernio, Publons, ScholarOne and the Institute for Scientific Information (ISI). The ‘university’ of the Web of Science Group, ISI maintains the knowledge corpus upon which the index and related information and analytical content, products, and services are built. The Web of Science Group is a Clarivate Analytics Plc company. www.webofsciencegroup.com e: ISI@clarivate.com @webofscience ISBN 978-1-9160868-3-8
3 2 The G20: Produces 80% G20 is a group of 19 leading economies, spread regionally around the globe, with the EU as an additional member, that represents more than 80% of GDP and two- thirds of global population. This meeting, as the world’s ‘premier forum for international co-operation’ takes place against a backdrop of increasing global trade tensions. Expectations are high that the G20 will continue to play a positive role in fostering economic opportunity and addressing challenges in the global landscape. The world’s most prosperous economies are also among the most innovative ones and innovation is driven first and foremost by research. Research boosts economic growth and drives progress as the benefits of research are realized through economic, social and cultural outcomes. Japan believes that more international co-operation is a driver of shared global prosperity and has asserted a G20 focus on three core issues: trade reform; technology as a creator of an innovative and inclusive society; and sustainability. In considering likely outcomes, it is valuable to recognize the influence not only of the G20 as a group, but also to assess the diverse profile and trajectories of each member. Collectively, the 19 countries in the G20 accounted for more than five million articles and reviews indexed in the Web of Science research publication and citation index for the last three years. That is over 70% of the global total. The Institute for Scientific Information (ISI) is uniquely placed to deliver a comparative research snapshot for each G20 nation, setting Web of Science data alongside other key metrics on people, finance and patenting. The countries profiled within this report are selective. We have chosen topics of current policy interest that we know, through our work with research funders and research institutions, are good signals of the health of the research base. Key factors that contribute to impactful research include: • Relative research funding within the wider economy: the EU’s ambition is for at least 3% of GDP by 2020 • Gender balance in the research workforce: UNESCO reports a global average of 30% of researchers to be female • International engagement: international collaboration accounts for about half of G20 output and produces some of the most impactful research • Open access to research: the EU is driving Plan S to make all publicly- funded research publications immediately accessible and one-third of G20 output in 2018 was published in an OA format • We also summarise publication output and citation impact and deconstruct these indicators by main research areas in sciences and humanities. The data are visualized through graphic analyses that include the Impact Profiles and Research Footprints that we have developed. These were discussed in detail in our January 2019 report ‘Profiles, not metrics’ (GRR 1). For this publication, the benchmark is either the average or the median for the G20 group as a whole. These visualizations are explained in notes preceding the national profile pages. There is no ranking of the countries profiled here, because that would not be meaningful. This is a not a report on comparative performance. These profiles cover some large, mature economies and some economies that are smaller or still building their research base. The time trend graphs show the progress of that development. These scorecards will help policy- makers, observers and reporters to track, applaud and critique that progress, including the diversification of the research workforce, the allocation of strong research funding and the shift to Open Access. of world population (World Bank, 2018) of global GDP (World Bank, 2018) Represents 87% Employs of the world’s researchers (OECD, 2015) 92% of global R&D (OECD, 2015) Spends 70% of global research papers (Web of Science, 2018) Publishes 65% Introduction The 2019 G20 Summit takes place in Osaka, Japan on June 28-29. What happens in the G20 affects the world and the G20 group is undoubtedly a driver in the global research system.
5 4 Executive summary Country Summary of research footprint Argentina GERD remains low at 0.53% GDP, and patenting is also relatively low, but while the research workforce is relatively small it is gender-balanced (53% female). Output per researcher is half G20 average. Publication via Open Access (OA) models is relatively high, especially in social sciences and humanities. The citation impact of publications is boosted by international collaboration: 11% of these papers are in the global top 10%. Australia Output has doubled in a decade – and is relatively high per researcher and per GERD - but it is levelling-out and purely domestic output is now dropping. Overall citation impact is above G20 average, boosted by international collaboration where 17.5% of papers are in the global top 10%. OA is around G20 average in science but well below this in other areas. Brazil OA has been a strong feature of output across all disciplines. The absence of key OECD data for Brazil means some other indicators are absent. Output growth has been steady, driven as much by domestic activity as by collaboration and is strongest in life sciences. As elsewhere, collaboration is a significant aspect of citation impact, which is otherwise below G20 average. Canada Output has risen by around 30% in a decade, and is strong in social sciences and health but, despite above average productivity, domestic output has been flat and is dropping. Citation impact is relatively good with 38% of publications above world average citation impact compared to 31% for the G20 as a whole. It is strongest in health and natural sciences. China There is an enormous research workforce (2 million researchers), a strong level of investment (GERD as 2% GDP) and relatively high patenting rates. Its output productivity is domestically driven, although below G20 average, and is particularly strong in science and technology. Average citation impact is rising and has reached G20 average, and the Impact Profile shows that 10% of its papers are in the global top 10%. France Only 27% of researchers are female, OA is below G20 average in most fields, and output both per researcher and per GERD funding is below average. Citation impact is relatively good in science, boosted by a high level of international collaboration now accounting for over 60% of all output while domestic output has been in decline: output per researcher has been static. Germany Investment is high with GERD at 3% of GDP, and output per GERD is below G20 average whereas output per researcher is around average. The citation impact of this research is relatively good, across both international and domestic activity, and secures a 12.6% share of the world’s top 10% of papers. Only 28% of researchers are female. OA has been below G20 average but is rising. India There is no readily available recent data on GERD for researchers, so we cannot index productivity, but volume output appears to be relatively low for such a large economy. International collaboration remains relatively low level and Open Access has been adopted only in bio-medicine. These factors all contribute to a relatively weak Impact Profile and low citation impact across all areas. Indonesia Research output is small but has trebled in a decade, across all disciplines. More than 75% of this output is internationally collaborative, so that also influences the Impact Profile. Average citation impact is relatively good in medicine and in social science and humanities, but domestic impact remains relatively low and over 40% of domestic papers are uncited. OA take up is good, but this is driven by very high OA in medicine. Italy Citation impact is relatively good in all areas, but output is only just above G20 median, which is surprising for a G7 research economy. The Impact Profile shows that average performance is boosted by international collaboration, which accounts for 55% of total output. Productivity figures (per GERD and per researcher) are well above average, so output is not constrained by consistently low investment. Country Summary of research footprint Japan Citation impact is relatively low for a well-established research economy with a high level of GERD/ GDP (3.2%). The Impact Profile shows that performance is lifted above the G20 average through international collaboration, although this is relatively low, at 30% of a total output that has remained very flat over the decade. Productivity is well below average and only 16% of the researcher population are female. Mexico Research investment remains relatively low (GERD/GDP is 0.49%) but rising output is boosted by high researcher productivity. However, citation impact has been flat over the decade and the Impact Profile shows that the performance of the domestic base remains below world average and overall impact has recently fallen compared to that benchmark. Only in medicine and health does impact match the world average. Russia Output has been recovering slowly from post-Soviet disruption and is close to G20 median in physical sciences but still low in engineering. Citation impact is boosted by rising international collaboration (38% of total) but share of global top 10% papers is low (4.2%) and the Impact Profile shows that domestic research is generally cited less than world average. Productivity by GERD and researcher is relatively low, and OA is exceptionally low. Saudi Arabia Average citation impact appears very high as only 20% of papers are domestic, and the bulk of the Impact Profile reflects a policy orientation towards international collaboration, or affiliation, that has grown steeply while domestic capacity has remained relatively static. Impact by discipline is consequently relatively high in all areas, compared both to G20 average and to the country’s substantive activity. South Africa The overall Impact Profile is close to G20 average, boosted by international collaboration (60% of output) that underpins a strong performance in medicine and health research. Productivity is high and output has been rising, although it remains relatively low in the G20. Open Access publication rates across disciplines are consistently high and female researchers make up an impressive 45% of the workforce. South Korea GERD/GDP (4.5%) is exceptionally high. This has not yet been translated into output, where productivity is well below G20 averages, or citation impact. The latter may partly be due to lower international collaboration than the G20 average. Female researchers are a relatively small part (20%) of the workforce. OA is rising and is already above G20 benchmarks. Turkey Output has recently declined and productivity by GERD and researcher has fallen throughout the decade. Citation impact has remained well below world average in all areas, boosted by international collaboration which remains low at 25% total output. Output is also relatively low across all areas, given the size of the economy and Open Access is declining relative to the G20 generally. United Kingdom The share of papers in the global top 10% (14.5%) is the highest in the G20 and the Impact Profile shows that the domestic research base is also well above group average. By discipline, average citation impact is relatively high (above 1.18) in most areas and only low in art and design. International collaboration is exceptionally high (63%) for such a large economy. The number of female researchers (39%) is above G20 average. United States Citation impact is consistent, though less than the UK, across all disciplines. The Impact Profile shows that the domestic research base is boosted less by international collaboration than for other countries. However, although GERD/GDP (2.8%) remains high, output and impact are in decline and output/ researcher has fallen below the G20 average. Publishing via OA models is on the rise but is below the G20 average.
7 6 0% 5% 10% 15% 20% 25% World average cites/paper = 1.0 U n c i t e d 0 < & < = 0 . 1 2 5 0 . 1 2 5 < & < = 0 . 2 5 0 . 2 5 < & < = 0 . 5 0 . 5 < & < = 1 1 < & < = 2 2 < & < = 4 4 < & < = 8 8 < U n c i t e d 0 < & < = 0 . 1 2 5 0 . 1 2 5 < & < = 0 . 2 5 0 . 2 5 < & < = 0 . 5 0 . 5 < & < = 1 1 < & < = 2 2 < & < = 4 4 < & < = 8 8 < Understanding the G20 scorecards The headlines on the left-hand page are about people: the population, the abundance of researchers in that population and the percentage of those researchers who are female Growth and impact of international collaboration The growth of Open Access and its spread by subject area An Impact Profile shows the spread of citation impact across a country’s research output Research Footprints show the balance of research impact by main field Trends in productivity by funding and researcher number The headlines on the right-hand page are about money and intellectual property: total GDP, Gross Expenditure on R&D (GERD), Business Expenditure on R&D (BERD) and the ratio of patents to BERD The research profile of each country is summarized across two pages of data, graphics and tables. Each profile is headed by key statistics for the country and graphs show the pattern of activity and performance by subject area or the distribution or trend in performance across the last ten years. Benchmarks. A country’s performance is better understood if it is contextualized, ideally against an appropriate reference value. The reference benchmark in the G20 scorecards is either the G20 average or the G20 median, and this is shown in all the graphics and tables. The reason for using median values in some instances is that research data can be very skewed, with many low values and a few high value outliers, so the average does not then reflect the mid-point of the distribution. There are no direct comparisons between individual countries. The G20 nations vary significantly in size and research maturity so direct comparison would not always be informative. In future reports, we expect to add information that tracks the evolving state of each country, benchmarking its activity against its historical position. Citation analysis: The significance of a paper (an article or review) in a research journal is measured by the number of times it is subsequently cited in later research. These citation counts grow over time at a rate that varies between research fields, so actual counts are ‘normalized’ for analysis using the global average for field and year of publication. This is called Category Normalized Citation Impact, or CNCI: values greater than 1.0 show a paper is cited more often than world average. Impact Profiles display the distribution of CNCI values for a ten-year sample of journal papers. The profile is much more informative than a single average value for the whole sample. Papers are assigned to categories as either uncited, or cited less often (down to half, less than half to one-quarter and so on), or cited more often (up to 2 times, 2-4 times and so on) than the world average (Adams et al., 2007). 45 44 Output by GERD Output and Open Access Impact by discipline Output by researcher Output and Open Access Output by discipline Papers per researcher (FTE) Papers per million GERD (PPP US$) United Kingdom Population 65,595,565 Researchers 510,980 Researchers / 1000 population 7.79 Female researchers 197,576 Women as % researchers 38.7 GDP (PPP US$ billions) 2965.8 Patents 53,746 GERD (PPP US$ billions) 49.3 BERD (PPP US$ billions) 33.3 GERD/GDP (%) 1.66 Patents/BERD 1611.8 Total and domestic papers per year Domestic papers (inc G20) Category normalised citation impact Open Access papers per year Open Access papers (inc G20) Impact profile Output and collaboration Impact and collaboration Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM Papers CNCI % > world average % in top 10% United Kingdom total 1,274,025 1.41 41.1% 14.5% United Kingdom domestic 550,634 1.10 35.0% 10.7% United Kingdom international 723,391 1.65 45.6% 17.4% G20 total dataset 15,164,121 0.99 31.3% 9.5% 0% 5% 10% 15% 20% 25% World average cites/paper = 1.0 U n c it e d 0 < & < = 0 .1 2 5 0 .1 2 5 < & < = 0 .2 5 0 .2 5 < & < = 0 .5 0 .5 < & < = 1 1 < & < = 2 2 < & < = 4 4 < & < = 8 8 < U n c it e d 0 < & < = 0 .1 2 5 0 .1 2 5 < & < = 0 .2 5 0 .2 5 < & < = 0 .5 0 .5 < & < = 1 1 < & < = 2 2 < & < = 4 4 < & < = 8 8 < 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM Data type Source Notes Population, GDP World Bank GDP (PPP) data are in current international $ https://databank.worldbank.org/data/reports.aspx?source=2&series=SP.POP. TOTL&country=# or https://databank.worldbank.org/data/reports.aspx?source=2&series=NY.GDP.MKTP.PP.CD&country= Researchers, GERD, BERD OECD, MSTI Most recent data for each, matched to related data for the corresponding same year from e.g. the World Bank. For example, if researcher data are from 2016, population and female researcher data are from 2016 to provide a meaningful comparison https://stats.oecd.org/ index.aspx GERD is Gross national Expenditure on R&D; BERD is Business-sector Expenditure on R&D; MSTI only includes MSTI only includes data for OECD members and Argentina, China, Romania, Russia, Singapore, South Africa and Taiwan. Data are therefore absent for Brazil, India, Indonesia or Saudi Arabia, except where obtained from other, validated sources. Researchers/ GERD OECD Data are 2009-2017 linearly interpolated where not available, and extended with earliest or latest value to cover the start/end of the period Patents WIPO Data are for 2017: World Intellectual Property Indicators 2018, Geneva: World Intellectual Property Organization. Table A59, p73 Publications, citations Web of Science Group InCites or Web of Science depending on the data point (2009-2018). Data are from the Science Citation Index Expanded, Social Sciences Citation Index and Arts & Humanities Citation Index, and only cover Articles and Reviews. Open Access DOAJ Data taken from WoS Group InCites, based on DOAJ Data sources. There are several sources of the data used in the headlines and elsewhere. The OECD is an important source of research information, particularly the Main Science & Technology Indicators (MSTI) but not all nations are OECD members and data may be missing where an OECD member has not consistently and recently updated their profile. Interpolation is used to fill these gaps. Data are shown as percentage papers in sample Uncited papers shown as a separate block Eight impact categories of cited papers: four below the world average citation impact and four above For each dataset, the table shows the count of papers, the average CNCI and the percentages of papers above world average and in the world’s top 10% Impact profile Three Impact Profile curves track CNCI for total national output, the impact for domestic papers and those with international collaborators Comparison to the Impact Profile for the complete G20 dataset Papers CNCI % > world average % in top 10% United Kingdom total 1,274,025 1.41 41.1% 14.5% United Kingdom domestic 550,634 1.10 35.0% 10.7% United Kingdom international 723,391 1.65 45.6% 17.4% G20 total dataset 15,164,121 0.99 31.3% 9.5%
9 Output by GERD Output and Open Access Impact by discipline Output by researcher Output and Open Access Output by discipline searcher (FTE) n GERD (PPP US$) United Kingdom Population 65,595,565 Researchers 510,980 Researchers / 1000 population 7.79 Female researchers 197,576 Women as % researchers 38.7 GDP (PPP US$ billions) 2965.8 Patents 53,746 GERD (PPP US$ billions) 49.3 BERD (PPP US$ billions) 33.3 GERD/GDP (%) 1.66 Patents/BERD 1611.8 ic papers per year Domestic paper sed citation impact Open Access papers per year Open Access papers (inc G20) Impact profile Output and collaboration Impact and collaboration Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM Papers CNCI % > world average % in top 10% United Kingdom total 1,274,025 1.41 41.1% 14.5% United Kingdom domestic 550,634 1.10 35.0% 10.7% United Kingdom international 723,391 1.65 45.6% 17.4% G20 total dataset 15,164,121 0.99 31.3% 9.5% 0% 5% 10% 15% 20% 25% World average cites/paper = 1.0 U n c i t e d 0 < & < = 0 . 1 2 5 0 . 1 2 5 < & < = 0 . 2 5 0 . 2 5 < & < = 0 . 5 0 . 5 < & < = 1 1 < & < = 2 2 < & < = 4 4 < & < = 8 8 < U n c i t e d 0 < & < = 0 . 1 2 5 0 . 1 2 5 < & < = 0 . 2 5 0 . 2 5 < & < = 0 . 5 0 . 5 < & < = 1 1 < & < = 2 2 < & < = 4 4 < & < = 8 8 < 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng A&H Soc 50% 75% 100% 80,000 100,000 120,000 140,000 160,000 1.00 1.50 2.00 1.00 1.50 2.00 2.50 3.00 3.50 0.20 0.30 0.40 0.50 0.60 Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng A&H Soc 75% 100% 120,000 140,000 160,000 1.50 2.00 2.00 2.50 3.00 3.50 0.30 0.40 0.50 0.60 Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 75% 100% 120,000 140,000 160,000 1.50 2.00 2.00 2.50 3.00 3.50 0.30 0.40 0.50 0.60 Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 40% 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 50% 75% 100% 80,000 100,000 120,000 140,000 160,000 1.00 1.50 2.00 1.00 1.50 2.00 2.50 3.00 3.50 0.20 0.30 0.40 0.50 0.60 Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 45 44 Output by GERD Output and Open Access Impact by discipline Output by researcher Output and Open Access Output by discipline Papers per researcher (FTE) Papers per million GERD (PPP US$) United Kingdom Population 65,595,565 Researchers 510,980 Researchers / 1000 population 7.79 Female researchers 197,576 Women as % researchers 38.7 GDP (PPP US$ billions) 2965.8 Patents 53,746 GERD (PPP US$ billions) 49.3 BERD (PPP US$ billions) 33.3 GERD/GDP (%) 1.66 Patents/BERD 1611.8 Total and domestic papers per year Domestic papers (inc G20) Category normalised citation impact Open Access papers per year Open Access papers (inc G20) Impact profile Output and collaboration Impact and collaboration Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM Papers CNCI % > world average % in top 10% United Kingdom total 1,274,025 1.41 41.1% 14.5% United Kingdom domestic 550,634 1.10 35.0% 10.7% United Kingdom international 723,391 1.65 45.6% 17.4% G20 total dataset 15,164,121 0.99 31.3% 9.5% 0% 5% 10% 15% 20% 25% World average cites/paper = 1.0 U n c i t e d 0 < & < = 0 . 1 2 5 0 . 1 2 5 < & < = 0 . 2 5 0 . 2 5 < & < = 0 . 5 0 . 5 < & < = 1 1 < & < = 2 2 < & < = 4 4 < & < = 8 8 < U n c i t e d 0 < & < = 0 . 1 2 5 0 . 1 2 5 < & < = 0 . 2 5 0 . 2 5 < & < = 0 . 5 0 . 5 < & < = 1 1 < & < = 2 2 < & < = 4 4 < & < = 8 8 < 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng A&H Soc 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 40% 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 Med Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng A&H Soc 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 40% 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 40% 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 40% 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 Med Life MPS Eng A&H Soc Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 45 Output by GERD Output and Open Access Impact by discipline Output by researcher Output and Open Access Output by discipline Papers per researcher (FTE) Papers per million GERD (PPP US$) GDP (PPP US$ billions) 2965.8 Patents 53,746 GERD (PPP US$ billions) 49.3 BERD (PPP US$ billions) 33.3 GERD/GDP (%) 1.66 Patents/BERD 1611.8 Open Access papers per year Open Access papers (inc G20) Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc Med Life MPS Eng A&D H&L Soc SAM 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc Med Life MPS Eng A&D H&L Soc SAM 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&D H&L AM Med Life MPS Eng A&D &L M 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 45 Output by GERD Output and Open Access Impact by discipline Output by researcher Output and Open Access Output by discipline Papers per researcher (FTE) Papers per million GERD (PPP US$) Domestic papers (inc G20) Category normalised citation impact Open Access papers per year Open Access papers (inc G20) Impact and collaboration Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM apers CNCI % > world average % in top 10% 274,025 1.41 41.1% 14.5% 550,634 1.10 35.0% 10.7% 723,391 1.65 45.6% 17.4% 164,121 0.99 31.3% 9.5% World average cites/paper = 1.0 < = 0 . 5 0 . 5 < & < = 1 1 < & < = 2 2 < & < = 4 4 < & < = 8 8 < < = 0 . 5 0 . 5 < & < = 1 1 < & < = 2 2 < & < = 4 4 < & < = 8 8 < 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 0.00 0.10 0.20 0.30 0.40 0.50 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc % 5% 0% 5% 00% 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng H oc Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc Eng A&D H&L Med Life MPS Eng A&D H&L Soc SAM 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0% 25% 50% 75% 100% 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc A&D Med Life MPS Eng A&D H&L Soc SAM 45 44 Output by GERD Output by researcher Papers per researcher (FTE) Papers per million GERD (PPP US$) Total and domestic papers per year Domestic papers (inc G20) Category normalised citation impact Open Access papers per year Open Access papers (inc G20) Output and collaboration Impact and collaboration Papers CNCI % > world average % in top 10% United Kingdom total 1,274,025 1.41 41.1% 14.5% United Kingdom domestic 550,634 1.10 35.0% 10.7% United Kingdom international 723,391 1.65 45.6% 17.4% G20 total dataset 15,164,121 0.99 31.3% 9.5% 0% U n c i t e d 0 < & < = 0 . 1 2 5 0 . 1 2 5 < & < = 0 . 2 5 0 . 2 5 < & < = 0 . 5 0 . 5 < & < = 1 1 < & < = 2 2 < & < = 4 4 < & < = 8 8 < U n c i t e d 0 < & < = 0 . 1 2 5 0 . 1 2 5 < & < = 0 . 2 5 0 . 2 5 < & < = 0 . 5 0 . 5 < & < = 1 1 < & < = 2 2 < & < = 4 4 < & < = 8 8 < 0% 10% 20% 30% 0 5,000 10,000 15,000 20,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Life MPS Eng A&H Soc 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc Eng A&D H&L 0% 10% 20% 30% 0 5,000 10,000 15,000 20,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Life MPS Eng A&H Soc 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc Life MPS Eng A&D H&L Soc SAM 0% 25% 50% 75% 100% 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc MPS Eng A&D H&L Soc 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc Eng A&D H&L 0% 25% 50% 75% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 0.00 0.50 1.00 1.50 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 0.00 0.10 0.20 0.30 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc Eng A&D H&L 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 Med Life MPS Eng A&H Soc Output trend is tracked over the last ten years Total paper count for the country The percentage of annual output that is still domestic Blue block is the count of domestic papers, with no international co-author G20 average percentage of annual output that is still domestic Trends in national OA output OA as a share of total output G20 average OA papers per year Country as a whole Papers with an international co-author G20 average CNCI Output and collaboration The citation impact of collaboration is shown by comparing average national impact with the papers that have an international co-author Impact and collaboration Impact by discipline Output by discipline Research productivity is analysed in terms of both output per unit GERD funding and output per researcher. Impact trend is tracked over the last ten years Research Footprints are supported by ‘spark lines’ showing ten-year trends by discipline group Each axis indicates the range of performance for a specific discipline group (see key) The maximum value on each axis is at the outer point and other values scale from there The dotted line shows the median value for the G20 The blue shape shows the Research Footprint for the country Research Footprints show how a research activity or performance measure varies across disciplines. They show the ‘footprint’ of the country on the global research landscape. The Research Footprints for publication output and for citation impact use eight major discipline groups (see key) within which there are broadly similar publication and citation patterns. Med = medicine Life = life sciences MPS = maths and physical sciences Eng = engineering and technology Soc = social sciences AH = arts and humanities AD = art and design HL = humanities and languages SAM = subjects allied to medicine ‘Open Access’ (OA) research publication, where the author or funder pays instead of the reader or a university library paying via journal subscription, is increasing in response to demands from research funders – including governments (see Global Research Report 2: The Plan S Footprint). The trends and patterns in OA research publication are shown in a graph and a Research Footprint. The Research Footprint uses only six axes because OA is still relatively scarce in humanities and social sciences. International collaboration in research has been growing and most of the world’s most highly-cited research now has authors from two or more countries. As a result, the specifically domestic part of each country’s research base has been shrinking and is contributing less to overall national impact (Adams, 2013). These graphs show the growth of collaboration and the contribution that it makes to average national citation impact. National performance G20 average papers per unit activity Output and Open Access Output and Open Access Average citation impact is shown relative to world average 8 Output by GERD Output and Open Access Impact by discipline Output by researcher Output and Open Access Output by discipline searcher (FTE) n GERD (PPP US$) United Kingdom Population 65,595,565 Researchers 510,980 Researchers / 1000 population 7.79 Female researchers 197,576 Women as % researchers 38.7 GDP (PPP US$ billions) 2965.8 Patents 53,746 GERD (PPP US$ billions) 49.3 BERD (PPP US$ billions) 33.3 GERD/GDP (%) 1.66 Patents/BERD 1611.8 ic papers per year Domestic paper sed citation impact Open Access papers per year Open Access papers (inc G20) Impact profile Output and collaboration Impact and collaboration Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM Papers CNCI % world average % in top 10% United Kingdom total 1,274,025 1.41 41.1% 14.5% United Kingdom domestic 550,634 1.10 35.0% 10.7% United Kingdom international 723,391 1.65 45.6% 17.4% G20 total dataset 15,164,121 0.99 31.3% 9.5% 0% 5% 10% 15% 20% 25% World average cites/paper = 1.0 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 50% 75% 100% 80,000 100,000 120,000 140,000 160,000 1.00 1.50 2.00 1.00 1.50 2.00 2.50 3.00 3.50 0.20 0.30 0.40 0.50 0.60 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 75% 100% 120,000 140,000 160,000 1.50 2.00 2.00 2.50 3.00 3.50 0.30 0.40 0.50 0.60 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 75% 100% 120,000 140,000 160,000 1.50 2.00 2.00 2.50 3.00 3.50 0.30 0.40 0.50 0.60 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 40% 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 50% 75% 100% 80,000 100,000 120,000 140,000 160,000 1.00 1.50 2.00 1.00 1.50 2.00 2.50 3.00 3.50 0.20 0.30 0.40 0.50 0.60 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM
11 10 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0.00 0.50 1.00 1.50 2.00 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc Output by GERD Output and Open Access Impact by discipline Output by researcher Output and Open Access Output by discipline Papers per researcher (FTE) Papers per million GERD (PPP US$) 0% 5% 10% 15% 20% 25% World average cites/paper = 1.0 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 Argentina Population 43,847,430 Researchers 83,947 Researchers / 1000 population 1.91 Female researchers 44,521 Women as % researchers 53.0 GDP (PPP US$ billions) 879.8 Patents 766 GERD (PPP US$ billions) 4.7 BERD (PPP US$ billions) 1.1 GERD/GDP (%) 0.53 Patents/BERD 684.7 Total and domestic papers per year Domestic papers (inc G20) Category normalised citation impact Open Access papers per year Open Access papers (inc G20) Impact profile Output and collaboration Impact and collaboration Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM Papers CNCI % world average % in top 10% Argentina total 98,448 0.92 25.8% 6.9% Argentina domestic 51,792 0.54 17.4% 2.9% Argentina international 46,656 1.34 35.1% 11.3% G20 total dataset 15,164,121 0.99 31.3% 9.5% 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0.00 0.50 1.00 1.50 2.00 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0.00 0.50 1.00 1.50 2.00 2.50 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0.00 0.50 1.00 1.50 2.00 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0.00 0.50 1.00 1.50 2.00 2.50 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0.00 0.50 1.00 1.50 2.00 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0.00 0.50 1.00 1.50 2.00 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0.00 0.50 1.00 1.50 2.00 2.50 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0.00 0.50 1.00 1.50 2.00 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0.00 0.50 1.00 1.50 2.00 2.50 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0.00 0.50 1.00 1.50 2.00 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 0 9 1 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 0.00 0.50 1.00 1.50 2.00 2.50 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0.00 0.50 1.00 1.50 2.00 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0.00 0.50 1.00 1.50 2.00 2.50 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0.00 0.50 1.00 1.50 2.00 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0.00 0.50 1.00 1.50 2.00 2.50 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AH Soc
13 12 Output by GERD Output and Open Access Impact by discipline Output by researcher Output and Open Access Output by discipline Papers per researcher (FTE) Papers per million GERD (PPP US$) 0% 5% 10% 15% 20% 25% World average cites/paper = 1.0 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 Australia Population 24,601,860 Researchers - Researchers / 1000 population - Female researchers - Women as % researchers 40% GDP (PPP US$ billions) 1099.9 Patents 11,656 GERD (PPP US$ billions) 21.2 BERD (PPP US$ billions) 11.3 GERD/GDP (%) 1.92 Patents/BERD 1031.4 Total and domestic papers per year Domestic papers (inc G20) Category normalised citation impact Open Access papers per year Open Access papers (inc G20) Impact profile Output and collaboration Impact and collaboration Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM Papers CNCI % world average % in top 10% Australia total 624,023 1.38 40.4% 14.0% Australia domestic 288,459 1.02 34.3% 9.8% Australia international 335,564 1.69 45.7% 17.5% G20 total dataset 15,164,121 0.99 31.3% 9.5% 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00 0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 0.80 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00 0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 0.80 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00 0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 0.80 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00 0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 0.80 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0 9 1 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00 0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 0.80 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00 0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 0.80 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00 0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 0.80 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM
15 14 Output by GERD Output and Open Access Impact by discipline Output by researcher Output and Open Access Output by discipline Papers per researcher (FTE) Papers per million GERD (PPP US$) 0% 5% 10% 15% 20% 25% World average cites/paper = 1.0 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 Brazil Population 209,288,278 Researchers - Researchers / 1000 population - Female researchers - Women as % researchers - GDP (PPP US$ billions) 3255.1 Patents 7,505 GERD (PPP US$ billions) - BERD (PPP US$ billions) - GERD/GDP (%) - Patents/BERD - Total and domestic papers per year Domestic papers (inc G20) Category normalised citation impact Open Access papers per year Open Access papers (inc G20) Impact profile Output and collaboration Impact and collaboration Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM Papers CNCI % world average % in top 10% Brazil total 463,357 0.79 23.3% 5.9% Brazil domestic 311,969 0.54 16.9% 3.1% Brazil international 151,388 1.30 36.6% 11.9% G20 total dataset 15,164,121 0.99 31.3% 9.5% 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0 9 1 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM
17 16 Output by GERD Output and Open Access Impact by discipline Output by researcher Output and Open Access Output by discipline Papers per researcher (FTE) Papers per million GERD (PPP US$) 0% 5% 10% 15% 20% 25% World average cites/paper = 1.0 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 Canada Population 36,708,083 Researchers - Researchers / 1000 population - Female researchers - Women as % researchers - GDP (PPP US$ billions) 1707.3 Patents 23,914 GERD (PPP US$ billions) 27.2 BERD (PPP US$ billions) 14.1 GERD/GDP (%) 1.59 Patents/BERD 1700.9 Total and domestic papers per year Domestic papers (inc G20) Category normalised citation impact Open Access papers per year Open Access papers (inc G20) Impact profile Output and collaboration Impact and collaboration Papers CNCI % world average % in top 10% Canada total 736,856 1.31 38.2% 12.8% Canada domestic 352,119 0.95 31.8% 8.6% Canada international 384,737 1.64 44.1% 16.6% G20 total dataset 15,164,121 0.99 31.3% 9.5% Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0 9 1 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM
19 18 Output by GERD Output and Open Access Impact by discipline Output by researcher Output and Open Access Output by discipline Papers per researcher (FTE) Papers per million GERD (PPP US$) 0% 5% 10% 15% 20% 25% World average cites/paper = 1.0 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 China Population 1,350,695,000 Researchers 2,069,650 Researchers / 1000 population 1.53 Female researchers - Women as % researchers - GDP (PPP US$ billions) 23350.2 Patents 1,306,019 GERD (PPP US$ billions) 496.0 BERD (PPP US$ billions) 384.8 GERD/GDP (%) 2.12 Patents/BERD 3393.8 Total and domestic papers per year Domestic papers (inc G20) Category normalised citation impact Open Access papers per year Open Access papers (inc G20) Impact profile Output and collaboration Impact and collaboration Papers CNCI % world average % in top 10% China total 2,741,465 1.01 31.1% 10.1% China domestic 2,039,968 0.86 27.6% 8.3% China international 701,497 1.44 41.2% 15.4% G20 total dataset 15,164,121 0.99 31.3% 9.5% Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 50,000 100,000 150,000 200,000 250,000 300,000 350,000 400,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 50,000 100,000 150,000 200,000 250,000 300,000 350,000 400,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 50,000 100,000 150,000 200,000 250,000 300,000 350,000 400,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 50,000 100,000 150,000 200,000 250,000 300,000 350,000 400,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 50,000 100,000 150,000 200,000 250,000 300,000 350,000 400,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0 9 1 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 50,000 100,000 150,000 200,000 250,000 300,000 350,000 400,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 50,000 100,000 150,000 200,000 250,000 300,000 350,000 400,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 50,000 100,000 150,000 200,000 250,000 300,000 350,000 400,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM
21 20 Output by GERD Output and Open Access Impact by discipline Output by researcher Output and Open Access Output by discipline Papers per researcher (FTE) Papers per million GERD (PPP US$) 0% 5% 10% 15% 20% 25% World average cites/paper = 1.0 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 France Population 66,593,366 Researchers 383,843 Researchers / 1000 population 5.76 Female researchers 103,521 Women as % researchers 27.0 GDP (PPP US$ billions) 2954.9 Patents 70,939 GERD (PPP US$ billions) 64.7 BERD (PPP US$ billions) 42.0 GERD/GDP (%) 2.19 Patents/BERD 1688.8 Total and domestic papers per year Domestic papers (inc G20) Category normalised citation impact Open Access papers per year Open Access papers (inc G20) Impact profile Output and collaboration Impact and collaboration Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM Papers CNCI % world average % in top 10% France total 818,118 1.22 36.0% 11.9% France domestic 351,729 0.83 27.8% 7.5% France international 466,389 1.50 42.2% 15.2% G20 total dataset 15,164,121 0.99 31.3% 9.5% 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0 9 1 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM
23 22 Output by GERD Output and Open Access Impact by discipline Output by researcher Output and Open Access Output by discipline Papers per researcher (FTE) Papers per million GERD (PPP US$) 0% 5% 10% 15% 20% 25% World average cites/paper = 1.0 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 Germany Population 81,686,611 Researchers 586,030 Researchers / 1000 population 7.17 Female researchers 164,095 Women as % researchers 28.0 GDP (PPP US$ billions) 4345.6 Patents 176,235 GERD (PPP US$ billions) 131.3 BERD (PPP US$ billions) 91.0 GERD/GDP (%) 3.02 Patents/BERD 1936.2 Total and domestic papers per year Domestic papers (inc G20) Category normalised citation impact Open Access papers per year Open Access papers (inc G20) Impact profile Output and collaboration Impact and collaboration Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM Papers CNCI % world average % in top 10% Germany total 1,172,143 1.25 37.4% 12.6% Germany domestic 534,443 0.90 29.5% 8.3% Germany international 637,700 1.54 44.0% 16.2% G20 total dataset 15,164,121 0.99 31.3% 9.5% 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0 9 1 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM
25 24 Output by GERD Output and Open Access Impact by discipline Output by researcher Output and Open Access Output by discipline Papers per researcher (FTE) Papers per million GERD (PPP US$) 0% 5% 10% 15% 20% 25% World average cites/paper = 1.0 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 India Population 1,339,180,127 Researchers - Researchers / 1000 population - Female researchers - Women as % researchers - GDP (PPP US$ billions) 9596.8 Patents 27,985 GERD (PPP US$ billions) - BERD (PPP US$ billions) - GERD/GDP (%) - Patents/BERD - Total and domestic papers per year Domestic papers (inc G20) Category normalised citation impact Open Access papers per year Open Access papers (inc G20) Impact profile Output and collaboration Impact and collaboration Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM Papers CNCI % world average % in top 10% India total 633,300 0.79 24.2% 6.6% India domestic 481,840 0.64 20.8% 5.0% India international 151,460 1.26 35.1% 11.9% G20 total dataset 15,164,121 0.99 31.3% 9.5% 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 1,000 2,000 3,000 4,000 5,000 6,000 7,000 8,000 9,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 1,000 2,000 3,000 4,000 5,000 6,000 7,000 8,000 9,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 1,000 2,000 3,000 4,000 5,000 6,000 7,000 8,000 9,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 1,000 2,000 3,000 4,000 5,000 6,000 7,000 8,000 9,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 1,000 2,000 3,000 4,000 5,000 6,000 7,000 8,000 9,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0 9 1 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM
27 26 Output by GERD Output and Open Access Impact by discipline Output by researcher Output and Open Access Output by discipline Papers per researcher (FTE) Papers per million GERD (PPP US$) 0% 5% 10% 15% 20% 25% 30% 35% 40% 45% World average cites/paper = 1.0 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 Indonesia Population 263,991,379 Researchers - Researchers / 1000 population - Female researchers - Women as % researchers - GDP (PPP US$ billions) 3249.6 Patents 2,320 GERD (PPP US$ billions) - BERD (PPP US$ billions) - GERD/GDP (%) - Patents/BERD - Total and domestic papers per year Domestic papers (inc G20) Category normalised citation impact Open Access papers per year Open Access papers (inc G20) Impact profile Output and collaboration Impact and collaboration Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM Papers CNCI % world average % in top 10% Indonesia total 20,828 1.05 28.3% 8.1% Indonesia domestic 3,838 0.44 13.3% 2.7% Indonesia international 16,990 1.18 31.7% 9.4% G20 total dataset 15,164,121 0.99 31.3% 9.5% 0% 25% 50% 75% 100% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 100 200 300 400 500 600 700 800 900 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 100 200 300 400 500 600 700 800 900 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 100 200 300 400 500 600 700 800 900 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 100 200 300 400 500 600 700 800 900 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 100 200 300 400 500 600 700 800 900 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0 9 1 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM
29 28 Output by GERD Output and Open Access Impact by discipline Output by researcher Output and Open Access Output by discipline Papers per researcher (FTE) Papers per million GERD (PPP US$) 0% 5% 10% 15% 20% 25% World average cites/paper = 1.0 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 Italy Population 60,627,498 Researchers 185,916 Researchers / 1000 population 3.07 Female researchers 65,431 Women as % researchers 35.2 GDP (PPP US$ billions) 2477.4 Patents 31,346 GERD (PPP US$ billions) 33.5 BERD (PPP US$ billions) 20.6 GERD/GDP (%) 1.35 Patents/BERD 1521.3 Total and domestic papers per year Domestic papers (inc G20) Category normalised citation impact Open Access papers per year Open Access papers (inc G20) Impact profile Output and collaboration Impact and collaboration Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM Papers CNCI % world average % in top 10% Italy total 713,369 1.24 37.5% 12.1% Italy domestic 364,725 0.88 30.3% 7.7% Italy international 348,644 1.61 45.1% 16.6% G20 total dataset 15,164,121 0.99 31.3% 9.5% 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 0.00 0.50 1.00 1.50 2.00 2.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 0.00 0.50 1.00 1.50 2.00 2.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 0.00 0.50 1.00 1.50 2.00 2.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0 9 1 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM
31 30 Output by GERD Output and Open Access Impact by discipline Output by researcher Output and Open Access Output by discipline Papers per researcher (FTE) Papers per million GERD (PPP US$) 0% 5% 10% 15% 20% 25% World average cites/paper = 1.0 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 Japan Population 126,785,797 Researchers 930,720 Researchers / 1000 population 7.34 Female researchers 150,545 Women as % researchers 16.2 GDP (PPP US$ billions) 5333.4 Patents 460,660 GERD (PPP US$ billions) 170.9 BERD (PPP US$ billions) 134.7 GERD/GDP (%) 3.20 Patents/BERD 3420.9 Total and domestic papers per year Domestic papers (inc G20) Category normalised citation impact Open Access papers per year Open Access papers (inc G20) Impact profile Output and collaboration Impact and collaboration Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM Papers CNCI % world average % in top 10% Japan total 899,903 0.87 25.6% 7.1% Japan domestic 629,161 0.66 20.6% 4.6% Japan international 270,742 1.34 37.1% 12.8% G20 total dataset 15,164,121 0.99 31.3% 9.5% 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0 9 1 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM
33 32 Output by GERD Output and Open Access Impact by discipline Output by researcher Output and Open Access Output by discipline Papers per researcher (FTE) Papers per million GERD (PPP US$) 0% 5% 10% 15% 20% 25% 30% World average cites/paper = 1.0 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 Mexico Population 122,535,969 Researchers 42,222 Researchers / 1000 population 0.34 Female researchers 13,943 Women as % researchers 33.0 GDP (PPP US$ billions) 2316.3 Patents 2,522 GERD (PPP US$ billions) 11.3 BERD (PPP US$ billions) 3.4 GERD/GDP (%) 0.49 Patents/BERD 733.0 Total and domestic papers per year Domestic papers (inc G20) Category normalised citation impact Open Access papers per year Open Access papers (inc G20) Impact profile Output and collaboration Impact and collaboration Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM Papers CNCI % world average % in top 10% Mexico total 143,215 0.81 22.3% 6.0% Mexico domestic 77,951 0.46 13.8% 2.4% Mexico international 65,264 1.23 32.5% 10.4% G20 total dataset 15,164,121 0.99 31.3% 9.5% 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 20,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 4,500 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 20,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 20,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 4,500 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 20,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 20,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 4,500 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 20,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 4,500 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 20,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 20,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 4,500 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0 9 1 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM
35 34 Output by GERD Output and Open Access Impact by discipline Output by researcher Output and Open Access Output by discipline Papers per researcher (FTE) Papers per million GERD (PPP US$) 0% 5% 10% 15% 20% 25% 30% 35% 40% World average cites/paper = 1.0 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 Russia Population 144,496,740 Researchers 359,793 Researchers / 1000 population 2.49 Female researchers 142,290 Women as % researchers 39.5 GDP (PPP US$ billions) 3783.1 Patents 27,782 GERD (PPP US$ billions) 41.9 BERD (PPP US$ billions) 25.2 GERD/GDP (%) 1.11 Patents/BERD 1103.3 Total and domestic papers per year Domestic papers (inc G20) Category normalised citation impact Open Access papers per year Open Access papers (inc G20) Impact profile Output and collaboration Impact and collaboration Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM Papers CNCI % world average % in top 10% Russia total 366,639 0.59 15.5% 4.2% Russia domestic 237,990 0.28 7.1% 1.2% Russia international 128,649 1.18 31.2% 9.9% G20 total dataset 15,164,121 0.99 31.3% 9.5% 0% 25% 50% 75% 100% 0 5,000 10,000 15,000 20,000 25,000 30,000 35,000 40,000 45,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 4,500 5,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 5,000 10,000 15,000 20,000 25,000 30,000 35,000 40,000 45,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 5,000 10,000 15,000 20,000 25,000 30,000 35,000 40,000 45,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 4,500 5,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 5,000 10,000 15,000 20,000 25,000 30,000 35,000 40,000 45,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 5,000 10,000 15,000 20,000 25,000 30,000 35,000 40,000 45,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 4,500 5,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 5,000 10,000 15,000 20,000 25,000 30,000 35,000 40,000 45,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 4,500 5,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 5,000 10,000 15,000 20,000 25,000 30,000 35,000 40,000 45,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 5,000 10,000 15,000 20,000 25,000 30,000 35,000 40,000 45,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 4,500 5,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0 9 1 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM
37 36 Output by GERD Output and Open Access Impact by discipline Output by researcher Output and Open Access Output by discipline Papers per researcher (FTE) Papers per million GERD (PPP US$) 0% 5% 10% 15% 20% 25% 30% World average cites/paper = 1.0 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 8 Saudi Arabia Population 32,938,213 Researchers - Researchers / 1000 population - Female researchers - Women as % researchers - GDP (PPP US$ billions) 1775.1 Patents 4,405 GERD (PPP US$ billions) - BERD (PPP US$ billions) - GERD/GDP (%) - Patents/BERD - Total and domestic papers per year Domestic papers (inc G20) Category normalised citation impact Open Access papers per year Open Access papers (inc G20) Impact profile Output and collaboration Impact and collaboration Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM Papers CNCI % world average % in top 10% Saudi Arabia total 109,417 1.27 33.1% 12.7% Saudi Arabia domestic 24,217 0.66 20.2% 5.6% Saudi Arabia international 85,200 1.45 36.8% 14.7% G20 total dataset 15,164,121 0.99 31.3% 9.5% 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0 9 1 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM
39 38 Output by GERD Output and Open Access Impact by discipline Output by researcher Output and Open Access Output by discipline Papers per researcher (FTE) Papers per million GERD (PPP US$) 0% 5% 10% 15% 20% 25% 30% World average cites/paper = 1.0 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 8 South Africa Population 55,291,225 Researchers 51,877 Researchers / 1000 population 0.94 Female researchers 23,334 Women as % researchers 45.0 GDP (PPP US$ billions) 730.9 Patents 2,178 GERD (PPP US$ billions) 5.8 BERD (PPP US$ billions) 2.5 GERD/GDP (%) 0.80 Patents/BERD 876.4 Total and domestic papers per year Domestic papers (inc G20) Category normalised citation impact Open Access papers per year Open Access papers (inc G20) Impact profile Output and collaboration Impact and collaboration Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM Papers CNCI % world average % in top 10% South Africa total 130,175 1.10 30.4% 9.5% South Africa domestic 57,665 0.59 19.3% 3.8% South Africa international 72,510 1.50 39.3% 14.1% G20 total dataset 15,164,121 0.99 31.3% 9.5% 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0 9 1 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM
41 40 Output by GERD Output and Open Access Impact by discipline Output by researcher Output and Open Access Output by discipline Papers per researcher (FTE) Papers per million GERD (PPP US$) 0% 5% 10% 15% 20% 25% World average cites/paper = 1.0 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 South Korea Population 51,466,201 Researchers 482,796 Researchers / 1000 population 9.38 Female researchers 97,042 Women as % researchers 20.1 GDP (PPP US$ billions) 1998.1 Patents 226,568 GERD (PPP US$ billions) 91.0 BERD (PPP US$ billions) 72.2 GERD/GDP (%) 4.55 Patents/BERD 3136.2 Total and domestic papers per year Domestic papers (inc G20) Category normalised citation impact Open Access papers per year Open Access papers (inc G20) Impact profile Output and collaboration Impact and collaboration Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM Papers CNCI % world average % in top 10% South Korea total 582,754 0.88 26.3% 7.6% South Korea domestic 410,239 0.68 22.1% 5.3% South Korea international 172,515 1.34 36.4% 12.9% G20 total dataset 15,164,121 0.99 31.3% 9.5% 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0 9 1 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM
43 42 Output by GERD Output and Open Access Impact by discipline Output by researcher Output and Open Access Output by discipline Papers per researcher (FTE) Papers per million GERD (PPP US$) 0% 5% 10% 15% 20% 25% 30% World average cites/paper = 1.0 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 8 Turkey Population 80,745,020 Researchers 210,769 Researchers / 1000 population 2.61 Female researchers 78,056 Women as % researchers 37.0 GDP (PPP US$ billions) 2261.0 Patents 11,144 GERD (PPP US$ billions) 21.7 BERD (PPP US$ billions) 12.4 GERD/GDP (%) 0.96 Patents/BERD 901.7 Total and domestic papers per year Domestic papers (inc G20) Category normalised citation impact Open Access papers per year Open Access papers (inc G20) Impact profile Output and collaboration Impact and collaboration Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM Papers CNCI % world average % in top 10% Turkey total 300,883 0.67 19.7% 5.2% Turkey domestic 235,602 0.50 15.3% 3.2% Turkey international 65,281 1.31 35.7% 12.6% G20 total dataset 15,164,121 0.99 31.3% 9.5% 0% 25% 50% 75% 100% 0 5,000 10,000 15,000 20,000 25,000 30,000 35,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 4,500 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 5,000 10,000 15,000 20,000 25,000 30,000 35,000 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 0.45 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 5,000 10,000 15,000 20,000 25,000 30,000 35,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 4,500 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 5,000 10,000 15,000 20,000 25,000 30,000 35,000 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 0.45 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 0.45 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 5,000 10,000 15,000 20,000 25,000 30,000 35,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 4,500 0.00 0.50 1.00 1.50 2.00 2.50 3.00 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 0.45 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 5,000 10,000 15,000 20,000 25,000 30,000 35,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 4,500 0.00 0.50 1.00 1.50 2.00 2.50 3.00 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 0.45 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 5,000 10,000 15,000 20,000 25,000 30,000 35,000 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 0.45 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 5,000 10,000 15,000 20,000 25,000 30,000 35,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 4,500 0.00 0.50 1.00 1.50 2.00 2.50 3.00 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 0.45 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0 9 1 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM
45 44 Output by GERD Output and Open Access Impact by discipline Output by researcher Output and Open Access Output by discipline Papers per researcher (FTE) Papers per million GERD (PPP US$) United Kingdom Population 65,595,565 Researchers 510,980 Researchers / 1000 population 7.79 Female researchers 197,576 Women as % researchers 38.7 GDP (PPP US$ billions) 2965.8 Patents 53,746 GERD (PPP US$ billions) 49.3 BERD (PPP US$ billions) 33.3 GERD/GDP (%) 1.66 Patents/BERD 1611.8 Total and domestic papers per year Domestic papers (inc G20) Category normalised citation impact Open Access papers per year Open Access papers (inc G20) Impact profile Output and collaboration Impact and collaboration Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM Papers CNCI % world average % in top 10% United Kingdom total 1,274,025 1.41 41.1% 14.5% United Kingdom domestic 550,634 1.10 35.0% 10.7% United Kingdom international 723,391 1.65 45.6% 17.4% G20 total dataset 15,164,121 0.99 31.3% 9.5% 0% 5% 10% 15% 20% 25% World average cites/paper = 1.0 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0 9 1 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM
47 46 Output by GERD Output and Open Access Impact by discipline Output by researcher Output and Open Access Output by discipline Papers per researcher (FTE) Papers per million GERD (PPP US$) 0% 5% 10% 15% 20% 25% World average cites/paper = 1.0 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 United States Population 325,147,121 Researchers - Researchers / 1000 population - Female researchers - Women as % researchers - GDP (PPP US$ billions) 19485.4 Patents 524,835 GERD (PPP US$ billions) 543.2 BERD (PPP US$ billions) 397.1 GERD/GDP (%) 2.79 Patents/BERD 1321.8 Total and domestic papers per year Domestic papers (inc G20) Category normalised citation impact Open Access papers per year Open Access papers (inc G20) Impact profile Output and collaboration Impact and collaboration Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM Papers CNCI % world average % in top 10% United States total 4,427,597 1.31 39.2% 13.5% United States domestic 2,819,840 1.17 36.4% 11.7% United States international 1,607,757 1.55 44.0% 16.5% G20 total dataset 15,164,121 0.99 31.3% 9.5% 0% 25% 50% 75% 100% 0 50,000 100,000 150,000 200,000 250,000 300,000 350,000 400,000 450,000 500,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 50,000 100,000 150,000 200,000 250,000 300,000 350,000 400,000 450,000 500,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 50,000 100,000 150,000 200,000 250,000 300,000 350,000 400,000 450,000 500,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 50,000 100,000 150,000 200,000 250,000 300,000 350,000 400,000 450,000 500,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 50,000 100,000 150,000 200,000 250,000 300,000 350,000 400,000 450,000 500,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 50,000 100,000 150,000 200,000 250,000 300,000 350,000 400,000 450,000 500,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 50,000 100,000 150,000 200,000 250,000 300,000 350,000 400,000 450,000 500,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 50,000 100,000 150,000 200,000 250,000 300,000 350,000 400,000 450,000 500,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0 9 1 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM
48 About the Global Research Report series from the Institute for Scientific Information (ISI) Global Research Reports is a new publication series from ISI which aims to inform and stimulate debate at the highest levels. The reports demonstrate the huge potential of research data to inform management issues in research assessment and research policy, and to accelerate development of the global research base. Previous reports include: GRR 1 - Profiles not metrics, January 2019 GRR 2 - The Plan S Footprint: Implications for the Scholarly Publishing Landscape, February 2019 GRR 3 – Navigating the Structure of Research on Sustainable Development Goals, April 2019 If you would like to sign up to receive our future reports or would like to find out more about the work of the Institute for Scientific Information, please do get in touch via email. We look forward to hearing from you. e: isi@clarivate.com Sign up to receive reports here: www.webofsciencegroup.com References 2013. Adams J. The fourth age of research. Nature, 497, 557-560. 2007. Adams J, Gurney K A and Marshall S. Profiling citation impact: a new methodology. Scientometrics, 72 (2), 325-344.
Contact our experts today: webofsciencegroup.com © 2019 Clarivate Analytics. Web of Science Group and its logo, as well as all other trademarks used herein are trademarks of their respective owners and used under license.

More Related Content

PDF
Evolving development goals in an evolving world report
The Economist Media Businesses
 
PDF
Turkey digital news report
Tel-Aviv Journalists' Association
 
PDF
Effect of Gender Equality on Economic Growth
Aashay Verma
 
PDF
Rural Livelihood Structure and Poverty in Tanzania
Dr. Hanifa Mohamed Yusuf
 
PDF
Ipsos Consumer Confidence: May 2014
Ipsos UK
 
PDF
GRR-India
Vinay Singh
 
PPTX
Welcome Speech At The Libsense Regional Open Science Policy Development Workshop
Elvis Muyanja
 
PPT
The changing atlas of world science
mpt001
 
Evolving development goals in an evolving world report
The Economist Media Businesses
 
Turkey digital news report
Tel-Aviv Journalists' Association
 
Effect of Gender Equality on Economic Growth
Aashay Verma
 
Rural Livelihood Structure and Poverty in Tanzania
Dr. Hanifa Mohamed Yusuf
 
Ipsos Consumer Confidence: May 2014
Ipsos UK
 
GRR-India
Vinay Singh
 
Welcome Speech At The Libsense Regional Open Science Policy Development Workshop
Elvis Muyanja
 
The changing atlas of world science
mpt001
 

Similar to The Annual G20 Scorecard – Research Performance 2019 (20)

PDF
UNESCO SCIENCE REPORT
Yorokobu
 
PDF
Unesco science-worldreport2010
acbconsultores
 
PPTX
Scoreboard- 2015 Japan Launch
innovationoecd
 
PDF
Unesco Science Report 2010 The Current Status Of Science Around The World Lid...
ahylintomppo
 
PDF
2020.01.12 OECD STI Outlook launch - Impacts of COVID-19: How STI systems res...
innovationoecd
 
PPT
The Journal Selection Process Spanish Research in Web of Science
Torres Salinas
 
PDF
Open Science: Expanding Frontiers in Research and Accelerating Innovation
WCIT 2014
 
PDF
Oecd Proceedings Social Sciences And Innovation Oecd
hsiaheyu
 
PPTX
Country rankings.pptx
Govt.college,Nagda, ujjain.M.P
 
PPTX
Chan aaas open_access_knowledgeisolation
CRDF Global
 
PDF
Final presentation - USAID Internship
Mary Ziemba
 
PDF
STI Outlook 2021
OECD Berlin Centre
 
PPTX
Rethinking Metrics of International Growth and Impact of Open Access
Leslie Chan
 
PPTX
Giulia Marsan_Open Science policy trends: evidence from OECD countries
Platforma Otwartej Nauki
 
PDF
Final Presentation - USAID Internship
Mary Ziemba
 
PDF
Innovation: managing risk, not avoiding it - report
bis_foresight
 
PDF
Global mobility of research scientists the economics of who goes where and wh...
farfalelfje
 
PDF
Global Research Report Brazil Jun09 1
nielsleidecker
 
PDF
Sabina Leonelli, Professor of Philosophy and History of Science, University o...
Kungliga biblioteket National Library of Sweden
 
PDF
Michael kahn cape town tand f indaba
Taylor & Francis (Africa)
 
UNESCO SCIENCE REPORT
Yorokobu
 
Unesco science-worldreport2010
acbconsultores
 
Scoreboard- 2015 Japan Launch
innovationoecd
 
Unesco Science Report 2010 The Current Status Of Science Around The World Lid...
ahylintomppo
 
2020.01.12 OECD STI Outlook launch - Impacts of COVID-19: How STI systems res...
innovationoecd
 
The Journal Selection Process Spanish Research in Web of Science
Torres Salinas
 
Open Science: Expanding Frontiers in Research and Accelerating Innovation
WCIT 2014
 
Oecd Proceedings Social Sciences And Innovation Oecd
hsiaheyu
 
Country rankings.pptx
Govt.college,Nagda, ujjain.M.P
 
Chan aaas open_access_knowledgeisolation
CRDF Global
 
Final presentation - USAID Internship
Mary Ziemba
 
STI Outlook 2021
OECD Berlin Centre
 
Rethinking Metrics of International Growth and Impact of Open Access
Leslie Chan
 
Giulia Marsan_Open Science policy trends: evidence from OECD countries
Platforma Otwartej Nauki
 
Final Presentation - USAID Internship
Mary Ziemba
 
Innovation: managing risk, not avoiding it - report
bis_foresight
 
Global mobility of research scientists the economics of who goes where and wh...
farfalelfje
 
Global Research Report Brazil Jun09 1
nielsleidecker
 
Sabina Leonelli, Professor of Philosophy and History of Science, University o...
Kungliga biblioteket National Library of Sweden
 
Michael kahn cape town tand f indaba
Taylor & Francis (Africa)
 
Ad

More from bhavesh lande (20)

PDF
information control and Security system
bhavesh lande
 
PDF
information technology and infrastructures choices
bhavesh lande
 
PDF
ethical issues,social issues
bhavesh lande
 
PDF
managing inforamation system
bhavesh lande
 
PDF
• E-commerce, e-business ,e-governance
bhavesh lande
 
PDF
IT and innovations
bhavesh lande
 
PDF
organisations and information systems
bhavesh lande
 
PDF
IT stratergy and digital goods
bhavesh lande
 
PDF
Implement Mapreduce with suitable example using MongoDB.
bhavesh lande
 
PDF
aggregation and indexing with suitable example using MongoDB.
bhavesh lande
 
PDF
Unnamed PL/SQL code block: Use of Control structure and Exception handling i...
bhavesh lande
 
PDF
database application using SQL DML statements: all types of Join, Sub-Query ...
bhavesh lande
 
PDF
database application using SQL DML statements: Insert, Select, Update, Delet...
bhavesh lande
 
PDF
Design and Develop SQL DDL statements which demonstrate the use of SQL objec...
bhavesh lande
 
PDF
working with python
bhavesh lande
 
PDF
applications and advantages of python
bhavesh lande
 
PDF
introduction of python in data science
bhavesh lande
 
PDF
tools
bhavesh lande
 
PDF
data scientists and their role
bhavesh lande
 
PDF
applications
bhavesh lande
 
information control and Security system
bhavesh lande
 
information technology and infrastructures choices
bhavesh lande
 
ethical issues,social issues
bhavesh lande
 
managing inforamation system
bhavesh lande
 
• E-commerce, e-business ,e-governance
bhavesh lande
 
IT and innovations
bhavesh lande
 
organisations and information systems
bhavesh lande
 
IT stratergy and digital goods
bhavesh lande
 
Implement Mapreduce with suitable example using MongoDB.
bhavesh lande
 
aggregation and indexing with suitable example using MongoDB.
bhavesh lande
 
Unnamed PL/SQL code block: Use of Control structure and Exception handling i...
bhavesh lande
 
database application using SQL DML statements: all types of Join, Sub-Query ...
bhavesh lande
 
database application using SQL DML statements: Insert, Select, Update, Delet...
bhavesh lande
 
Design and Develop SQL DDL statements which demonstrate the use of SQL objec...
bhavesh lande
 
working with python
bhavesh lande
 
applications and advantages of python
bhavesh lande
 
introduction of python in data science
bhavesh lande
 
tools
bhavesh lande
 
data scientists and their role
bhavesh lande
 
applications
bhavesh lande
 
Ad

Recently uploaded (20)

PDF
2.FourierTransform-ShortQuestionswithAnswers.pdf
Raji Murugan
 
PDF
STATICS OF THE RIGID BODIES Hibbelers.pdf
pascualasturiaskaye4
 
PDF
O7-L3 Supply Chain Operations - ICLT Program
labyankof
 
PDF
Abdominal Access Techniques with Prof. Dr. R K Mishra
mohitsuren827
 
PPTX
Introduction to Child Health Nursing – Unit I | Child Health Nursing I | B.Sc...
RAKESH SAJJAN
 
PDF
Open folder Downloads.pdf yes yes ges yes
JaybeeMacadangdang
 
PDF
01-Introduction-to-Information-Management.pdf
PrinceIbarra
 
PDF
Insiders guide to clinical Medicine.pdf
AbhishekPatil315128
 
PPTX
IMMUNITY IMMUNITY refers to protection against infection, and the immune syst...
shilpa939953
 
PDF
ANTIBIOTICS.pptx.pdf………………… xxxxxxxxxxxxx
HakHe
 
PDF
Saundersa Comprehensive Review for the NCLEX-RN Examination.pdf
sreejithcareers
 
PPTX
Microbial diseases, their pathogenesis and prophylaxis
DevlinaSengupta
 
PPTX
PPH.pptx obstetrics and gynecology in nursing
SrideviDevaraj5
 
PPTX
Pharmacology of Heart Failure /Pharmacotherapy of CHF
Rajshri Ghogare
 
PPTX
GDM (1) (1).pptx small presentation for students
shrawanbpkihs
 
PDF
Microbial disease of the cardiovascular and lymphatic systems
KeyaSharma
 
PDF
Pre independence Education in Inndia.pdf
goofy5603
 
PDF
Origin of periodic table-Mendeleev’s Periodic-Modern Periodic table
Mithil Fal Desai
 
PDF
Anesthesia in Laparoscopic Surgery in India
mohitsuren827
 
PPTX
Week 4 Term 3 Study Techniques revisited.pptx
mansk2
 
2.FourierTransform-ShortQuestionswithAnswers.pdf
Raji Murugan
 
STATICS OF THE RIGID BODIES Hibbelers.pdf
pascualasturiaskaye4
 
O7-L3 Supply Chain Operations - ICLT Program
labyankof
 
Abdominal Access Techniques with Prof. Dr. R K Mishra
mohitsuren827
 
Introduction to Child Health Nursing – Unit I | Child Health Nursing I | B.Sc...
RAKESH SAJJAN
 
Open folder Downloads.pdf yes yes ges yes
JaybeeMacadangdang
 
01-Introduction-to-Information-Management.pdf
PrinceIbarra
 
Insiders guide to clinical Medicine.pdf
AbhishekPatil315128
 
IMMUNITY IMMUNITY refers to protection against infection, and the immune syst...
shilpa939953
 
ANTIBIOTICS.pptx.pdf………………… xxxxxxxxxxxxx
HakHe
 
Saundersa Comprehensive Review for the NCLEX-RN Examination.pdf
sreejithcareers
 
Microbial diseases, their pathogenesis and prophylaxis
DevlinaSengupta
 
PPH.pptx obstetrics and gynecology in nursing
SrideviDevaraj5
 
Pharmacology of Heart Failure /Pharmacotherapy of CHF
Rajshri Ghogare
 
GDM (1) (1).pptx small presentation for students
shrawanbpkihs
 
Microbial disease of the cardiovascular and lymphatic systems
KeyaSharma
 
Pre independence Education in Inndia.pdf
goofy5603
 
Origin of periodic table-Mendeleev’s Periodic-Modern Periodic table
Mithil Fal Desai
 
Anesthesia in Laparoscopic Surgery in India
mohitsuren827
 
Week 4 Term 3 Study Techniques revisited.pptx
mansk2
 

The Annual G20 Scorecard – Research Performance 2019

  • 1. The Annual G20 Scorecard – Research Performance 2019 Professor Jonathan Adams, Gordon Rogers & Dr Martin Szomszor
  • 2. 1 Professor Jonathan Adams is Director at the Institute for Scientific Information, at the Web of Science Group. He is also a Visiting Professor at King’s College London, Policy Institute, and was awarded an Honorary D.Sc. in 2017 by the University of Exeter, for his work in higher education and research policy. Dr. Martin Szomszor is Head of Research Analytics at the Institute for Scientific Information. He joined from Digital Science, where, as Chief Data Scientist he applied his extensive knowledge of machine learning, data integration and visualization techniques to found the Global Research Identifier Database. He was named a 2015 top-50 UK Information Age data leader for his work in creating the REF2015 impact case studies database for the Higher Education Funding Council for England (HEFCE). Gordon Rogers is a Senior Data Scientist at the Institute for Scientific Information. He has worked in the fields of bibliometrics and data analysis for the past 10 years, supporting clients around the world in evaluating their research portfolio and strategy. Author biographies About the Web of Science Group The Web of Science Group organizes the world’s research information to enable academia, corporations, publishers and governments accelerate the pace of research. It is powered by the Web of Science – the world’s largest publisher-neutral citation index and research intelligence platform. Its many well-known brands also include Converis, EndNote, Kopernio, Publons, ScholarOne and the Institute for Scientific Information (ISI). The ‘university’ of the Web of Science Group, ISI maintains the knowledge corpus upon which the index and related information and analytical content, products, and services are built. The Web of Science Group is a Clarivate Analytics Plc company. www.webofsciencegroup.com e: ISI@clarivate.com @webofscience ISBN 978-1-9160868-3-8
  • 3. 3 2 The G20: Produces 80% G20 is a group of 19 leading economies, spread regionally around the globe, with the EU as an additional member, that represents more than 80% of GDP and two- thirds of global population. This meeting, as the world’s ‘premier forum for international co-operation’ takes place against a backdrop of increasing global trade tensions. Expectations are high that the G20 will continue to play a positive role in fostering economic opportunity and addressing challenges in the global landscape. The world’s most prosperous economies are also among the most innovative ones and innovation is driven first and foremost by research. Research boosts economic growth and drives progress as the benefits of research are realized through economic, social and cultural outcomes. Japan believes that more international co-operation is a driver of shared global prosperity and has asserted a G20 focus on three core issues: trade reform; technology as a creator of an innovative and inclusive society; and sustainability. In considering likely outcomes, it is valuable to recognize the influence not only of the G20 as a group, but also to assess the diverse profile and trajectories of each member. Collectively, the 19 countries in the G20 accounted for more than five million articles and reviews indexed in the Web of Science research publication and citation index for the last three years. That is over 70% of the global total. The Institute for Scientific Information (ISI) is uniquely placed to deliver a comparative research snapshot for each G20 nation, setting Web of Science data alongside other key metrics on people, finance and patenting. The countries profiled within this report are selective. We have chosen topics of current policy interest that we know, through our work with research funders and research institutions, are good signals of the health of the research base. Key factors that contribute to impactful research include: • Relative research funding within the wider economy: the EU’s ambition is for at least 3% of GDP by 2020 • Gender balance in the research workforce: UNESCO reports a global average of 30% of researchers to be female • International engagement: international collaboration accounts for about half of G20 output and produces some of the most impactful research • Open access to research: the EU is driving Plan S to make all publicly- funded research publications immediately accessible and one-third of G20 output in 2018 was published in an OA format • We also summarise publication output and citation impact and deconstruct these indicators by main research areas in sciences and humanities. The data are visualized through graphic analyses that include the Impact Profiles and Research Footprints that we have developed. These were discussed in detail in our January 2019 report ‘Profiles, not metrics’ (GRR 1). For this publication, the benchmark is either the average or the median for the G20 group as a whole. These visualizations are explained in notes preceding the national profile pages. There is no ranking of the countries profiled here, because that would not be meaningful. This is a not a report on comparative performance. These profiles cover some large, mature economies and some economies that are smaller or still building their research base. The time trend graphs show the progress of that development. These scorecards will help policy- makers, observers and reporters to track, applaud and critique that progress, including the diversification of the research workforce, the allocation of strong research funding and the shift to Open Access. of world population (World Bank, 2018) of global GDP (World Bank, 2018) Represents 87% Employs of the world’s researchers (OECD, 2015) 92% of global R&D (OECD, 2015) Spends 70% of global research papers (Web of Science, 2018) Publishes 65% Introduction The 2019 G20 Summit takes place in Osaka, Japan on June 28-29. What happens in the G20 affects the world and the G20 group is undoubtedly a driver in the global research system.
  • 4. 5 4 Executive summary Country Summary of research footprint Argentina GERD remains low at 0.53% GDP, and patenting is also relatively low, but while the research workforce is relatively small it is gender-balanced (53% female). Output per researcher is half G20 average. Publication via Open Access (OA) models is relatively high, especially in social sciences and humanities. The citation impact of publications is boosted by international collaboration: 11% of these papers are in the global top 10%. Australia Output has doubled in a decade – and is relatively high per researcher and per GERD - but it is levelling-out and purely domestic output is now dropping. Overall citation impact is above G20 average, boosted by international collaboration where 17.5% of papers are in the global top 10%. OA is around G20 average in science but well below this in other areas. Brazil OA has been a strong feature of output across all disciplines. The absence of key OECD data for Brazil means some other indicators are absent. Output growth has been steady, driven as much by domestic activity as by collaboration and is strongest in life sciences. As elsewhere, collaboration is a significant aspect of citation impact, which is otherwise below G20 average. Canada Output has risen by around 30% in a decade, and is strong in social sciences and health but, despite above average productivity, domestic output has been flat and is dropping. Citation impact is relatively good with 38% of publications above world average citation impact compared to 31% for the G20 as a whole. It is strongest in health and natural sciences. China There is an enormous research workforce (2 million researchers), a strong level of investment (GERD as 2% GDP) and relatively high patenting rates. Its output productivity is domestically driven, although below G20 average, and is particularly strong in science and technology. Average citation impact is rising and has reached G20 average, and the Impact Profile shows that 10% of its papers are in the global top 10%. France Only 27% of researchers are female, OA is below G20 average in most fields, and output both per researcher and per GERD funding is below average. Citation impact is relatively good in science, boosted by a high level of international collaboration now accounting for over 60% of all output while domestic output has been in decline: output per researcher has been static. Germany Investment is high with GERD at 3% of GDP, and output per GERD is below G20 average whereas output per researcher is around average. The citation impact of this research is relatively good, across both international and domestic activity, and secures a 12.6% share of the world’s top 10% of papers. Only 28% of researchers are female. OA has been below G20 average but is rising. India There is no readily available recent data on GERD for researchers, so we cannot index productivity, but volume output appears to be relatively low for such a large economy. International collaboration remains relatively low level and Open Access has been adopted only in bio-medicine. These factors all contribute to a relatively weak Impact Profile and low citation impact across all areas. Indonesia Research output is small but has trebled in a decade, across all disciplines. More than 75% of this output is internationally collaborative, so that also influences the Impact Profile. Average citation impact is relatively good in medicine and in social science and humanities, but domestic impact remains relatively low and over 40% of domestic papers are uncited. OA take up is good, but this is driven by very high OA in medicine. Italy Citation impact is relatively good in all areas, but output is only just above G20 median, which is surprising for a G7 research economy. The Impact Profile shows that average performance is boosted by international collaboration, which accounts for 55% of total output. Productivity figures (per GERD and per researcher) are well above average, so output is not constrained by consistently low investment. Country Summary of research footprint Japan Citation impact is relatively low for a well-established research economy with a high level of GERD/ GDP (3.2%). The Impact Profile shows that performance is lifted above the G20 average through international collaboration, although this is relatively low, at 30% of a total output that has remained very flat over the decade. Productivity is well below average and only 16% of the researcher population are female. Mexico Research investment remains relatively low (GERD/GDP is 0.49%) but rising output is boosted by high researcher productivity. However, citation impact has been flat over the decade and the Impact Profile shows that the performance of the domestic base remains below world average and overall impact has recently fallen compared to that benchmark. Only in medicine and health does impact match the world average. Russia Output has been recovering slowly from post-Soviet disruption and is close to G20 median in physical sciences but still low in engineering. Citation impact is boosted by rising international collaboration (38% of total) but share of global top 10% papers is low (4.2%) and the Impact Profile shows that domestic research is generally cited less than world average. Productivity by GERD and researcher is relatively low, and OA is exceptionally low. Saudi Arabia Average citation impact appears very high as only 20% of papers are domestic, and the bulk of the Impact Profile reflects a policy orientation towards international collaboration, or affiliation, that has grown steeply while domestic capacity has remained relatively static. Impact by discipline is consequently relatively high in all areas, compared both to G20 average and to the country’s substantive activity. South Africa The overall Impact Profile is close to G20 average, boosted by international collaboration (60% of output) that underpins a strong performance in medicine and health research. Productivity is high and output has been rising, although it remains relatively low in the G20. Open Access publication rates across disciplines are consistently high and female researchers make up an impressive 45% of the workforce. South Korea GERD/GDP (4.5%) is exceptionally high. This has not yet been translated into output, where productivity is well below G20 averages, or citation impact. The latter may partly be due to lower international collaboration than the G20 average. Female researchers are a relatively small part (20%) of the workforce. OA is rising and is already above G20 benchmarks. Turkey Output has recently declined and productivity by GERD and researcher has fallen throughout the decade. Citation impact has remained well below world average in all areas, boosted by international collaboration which remains low at 25% total output. Output is also relatively low across all areas, given the size of the economy and Open Access is declining relative to the G20 generally. United Kingdom The share of papers in the global top 10% (14.5%) is the highest in the G20 and the Impact Profile shows that the domestic research base is also well above group average. By discipline, average citation impact is relatively high (above 1.18) in most areas and only low in art and design. International collaboration is exceptionally high (63%) for such a large economy. The number of female researchers (39%) is above G20 average. United States Citation impact is consistent, though less than the UK, across all disciplines. The Impact Profile shows that the domestic research base is boosted less by international collaboration than for other countries. However, although GERD/GDP (2.8%) remains high, output and impact are in decline and output/ researcher has fallen below the G20 average. Publishing via OA models is on the rise but is below the G20 average.
  • 5. 7 6 0% 5% 10% 15% 20% 25% World average cites/paper = 1.0 U n c i t e d 0 < & < = 0 . 1 2 5 0 . 1 2 5 < & < = 0 . 2 5 0 . 2 5 < & < = 0 . 5 0 . 5 < & < = 1 1 < & < = 2 2 < & < = 4 4 < & < = 8 8 < U n c i t e d 0 < & < = 0 . 1 2 5 0 . 1 2 5 < & < = 0 . 2 5 0 . 2 5 < & < = 0 . 5 0 . 5 < & < = 1 1 < & < = 2 2 < & < = 4 4 < & < = 8 8 < Understanding the G20 scorecards The headlines on the left-hand page are about people: the population, the abundance of researchers in that population and the percentage of those researchers who are female Growth and impact of international collaboration The growth of Open Access and its spread by subject area An Impact Profile shows the spread of citation impact across a country’s research output Research Footprints show the balance of research impact by main field Trends in productivity by funding and researcher number The headlines on the right-hand page are about money and intellectual property: total GDP, Gross Expenditure on R&D (GERD), Business Expenditure on R&D (BERD) and the ratio of patents to BERD The research profile of each country is summarized across two pages of data, graphics and tables. Each profile is headed by key statistics for the country and graphs show the pattern of activity and performance by subject area or the distribution or trend in performance across the last ten years. Benchmarks. A country’s performance is better understood if it is contextualized, ideally against an appropriate reference value. The reference benchmark in the G20 scorecards is either the G20 average or the G20 median, and this is shown in all the graphics and tables. The reason for using median values in some instances is that research data can be very skewed, with many low values and a few high value outliers, so the average does not then reflect the mid-point of the distribution. There are no direct comparisons between individual countries. The G20 nations vary significantly in size and research maturity so direct comparison would not always be informative. In future reports, we expect to add information that tracks the evolving state of each country, benchmarking its activity against its historical position. Citation analysis: The significance of a paper (an article or review) in a research journal is measured by the number of times it is subsequently cited in later research. These citation counts grow over time at a rate that varies between research fields, so actual counts are ‘normalized’ for analysis using the global average for field and year of publication. This is called Category Normalized Citation Impact, or CNCI: values greater than 1.0 show a paper is cited more often than world average. Impact Profiles display the distribution of CNCI values for a ten-year sample of journal papers. The profile is much more informative than a single average value for the whole sample. Papers are assigned to categories as either uncited, or cited less often (down to half, less than half to one-quarter and so on), or cited more often (up to 2 times, 2-4 times and so on) than the world average (Adams et al., 2007). 45 44 Output by GERD Output and Open Access Impact by discipline Output by researcher Output and Open Access Output by discipline Papers per researcher (FTE) Papers per million GERD (PPP US$) United Kingdom Population 65,595,565 Researchers 510,980 Researchers / 1000 population 7.79 Female researchers 197,576 Women as % researchers 38.7 GDP (PPP US$ billions) 2965.8 Patents 53,746 GERD (PPP US$ billions) 49.3 BERD (PPP US$ billions) 33.3 GERD/GDP (%) 1.66 Patents/BERD 1611.8 Total and domestic papers per year Domestic papers (inc G20) Category normalised citation impact Open Access papers per year Open Access papers (inc G20) Impact profile Output and collaboration Impact and collaboration Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM Papers CNCI % > world average % in top 10% United Kingdom total 1,274,025 1.41 41.1% 14.5% United Kingdom domestic 550,634 1.10 35.0% 10.7% United Kingdom international 723,391 1.65 45.6% 17.4% G20 total dataset 15,164,121 0.99 31.3% 9.5% 0% 5% 10% 15% 20% 25% World average cites/paper = 1.0 U n c it e d 0 < & < = 0 .1 2 5 0 .1 2 5 < & < = 0 .2 5 0 .2 5 < & < = 0 .5 0 .5 < & < = 1 1 < & < = 2 2 < & < = 4 4 < & < = 8 8 < U n c it e d 0 < & < = 0 .1 2 5 0 .1 2 5 < & < = 0 .2 5 0 .2 5 < & < = 0 .5 0 .5 < & < = 1 1 < & < = 2 2 < & < = 4 4 < & < = 8 8 < 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM Data type Source Notes Population, GDP World Bank GDP (PPP) data are in current international $ https://databank.worldbank.org/data/reports.aspx?source=2&series=SP.POP. TOTL&country=# or https://databank.worldbank.org/data/reports.aspx?source=2&series=NY.GDP.MKTP.PP.CD&country= Researchers, GERD, BERD OECD, MSTI Most recent data for each, matched to related data for the corresponding same year from e.g. the World Bank. For example, if researcher data are from 2016, population and female researcher data are from 2016 to provide a meaningful comparison https://stats.oecd.org/ index.aspx GERD is Gross national Expenditure on R&D; BERD is Business-sector Expenditure on R&D; MSTI only includes MSTI only includes data for OECD members and Argentina, China, Romania, Russia, Singapore, South Africa and Taiwan. Data are therefore absent for Brazil, India, Indonesia or Saudi Arabia, except where obtained from other, validated sources. Researchers/ GERD OECD Data are 2009-2017 linearly interpolated where not available, and extended with earliest or latest value to cover the start/end of the period Patents WIPO Data are for 2017: World Intellectual Property Indicators 2018, Geneva: World Intellectual Property Organization. Table A59, p73 Publications, citations Web of Science Group InCites or Web of Science depending on the data point (2009-2018). Data are from the Science Citation Index Expanded, Social Sciences Citation Index and Arts & Humanities Citation Index, and only cover Articles and Reviews. Open Access DOAJ Data taken from WoS Group InCites, based on DOAJ Data sources. There are several sources of the data used in the headlines and elsewhere. The OECD is an important source of research information, particularly the Main Science & Technology Indicators (MSTI) but not all nations are OECD members and data may be missing where an OECD member has not consistently and recently updated their profile. Interpolation is used to fill these gaps. Data are shown as percentage papers in sample Uncited papers shown as a separate block Eight impact categories of cited papers: four below the world average citation impact and four above For each dataset, the table shows the count of papers, the average CNCI and the percentages of papers above world average and in the world’s top 10% Impact profile Three Impact Profile curves track CNCI for total national output, the impact for domestic papers and those with international collaborators Comparison to the Impact Profile for the complete G20 dataset Papers CNCI % > world average % in top 10% United Kingdom total 1,274,025 1.41 41.1% 14.5% United Kingdom domestic 550,634 1.10 35.0% 10.7% United Kingdom international 723,391 1.65 45.6% 17.4% G20 total dataset 15,164,121 0.99 31.3% 9.5%
  • 6. 9 Output by GERD Output and Open Access Impact by discipline Output by researcher Output and Open Access Output by discipline searcher (FTE) n GERD (PPP US$) United Kingdom Population 65,595,565 Researchers 510,980 Researchers / 1000 population 7.79 Female researchers 197,576 Women as % researchers 38.7 GDP (PPP US$ billions) 2965.8 Patents 53,746 GERD (PPP US$ billions) 49.3 BERD (PPP US$ billions) 33.3 GERD/GDP (%) 1.66 Patents/BERD 1611.8 ic papers per year Domestic paper sed citation impact Open Access papers per year Open Access papers (inc G20) Impact profile Output and collaboration Impact and collaboration Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM Papers CNCI % > world average % in top 10% United Kingdom total 1,274,025 1.41 41.1% 14.5% United Kingdom domestic 550,634 1.10 35.0% 10.7% United Kingdom international 723,391 1.65 45.6% 17.4% G20 total dataset 15,164,121 0.99 31.3% 9.5% 0% 5% 10% 15% 20% 25% World average cites/paper = 1.0 U n c i t e d 0 < & < = 0 . 1 2 5 0 . 1 2 5 < & < = 0 . 2 5 0 . 2 5 < & < = 0 . 5 0 . 5 < & < = 1 1 < & < = 2 2 < & < = 4 4 < & < = 8 8 < U n c i t e d 0 < & < = 0 . 1 2 5 0 . 1 2 5 < & < = 0 . 2 5 0 . 2 5 < & < = 0 . 5 0 . 5 < & < = 1 1 < & < = 2 2 < & < = 4 4 < & < = 8 8 < 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng A&H Soc 50% 75% 100% 80,000 100,000 120,000 140,000 160,000 1.00 1.50 2.00 1.00 1.50 2.00 2.50 3.00 3.50 0.20 0.30 0.40 0.50 0.60 Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng A&H Soc 75% 100% 120,000 140,000 160,000 1.50 2.00 2.00 2.50 3.00 3.50 0.30 0.40 0.50 0.60 Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 75% 100% 120,000 140,000 160,000 1.50 2.00 2.00 2.50 3.00 3.50 0.30 0.40 0.50 0.60 Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 40% 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 50% 75% 100% 80,000 100,000 120,000 140,000 160,000 1.00 1.50 2.00 1.00 1.50 2.00 2.50 3.00 3.50 0.20 0.30 0.40 0.50 0.60 Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 45 44 Output by GERD Output and Open Access Impact by discipline Output by researcher Output and Open Access Output by discipline Papers per researcher (FTE) Papers per million GERD (PPP US$) United Kingdom Population 65,595,565 Researchers 510,980 Researchers / 1000 population 7.79 Female researchers 197,576 Women as % researchers 38.7 GDP (PPP US$ billions) 2965.8 Patents 53,746 GERD (PPP US$ billions) 49.3 BERD (PPP US$ billions) 33.3 GERD/GDP (%) 1.66 Patents/BERD 1611.8 Total and domestic papers per year Domestic papers (inc G20) Category normalised citation impact Open Access papers per year Open Access papers (inc G20) Impact profile Output and collaboration Impact and collaboration Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM Papers CNCI % > world average % in top 10% United Kingdom total 1,274,025 1.41 41.1% 14.5% United Kingdom domestic 550,634 1.10 35.0% 10.7% United Kingdom international 723,391 1.65 45.6% 17.4% G20 total dataset 15,164,121 0.99 31.3% 9.5% 0% 5% 10% 15% 20% 25% World average cites/paper = 1.0 U n c i t e d 0 < & < = 0 . 1 2 5 0 . 1 2 5 < & < = 0 . 2 5 0 . 2 5 < & < = 0 . 5 0 . 5 < & < = 1 1 < & < = 2 2 < & < = 4 4 < & < = 8 8 < U n c i t e d 0 < & < = 0 . 1 2 5 0 . 1 2 5 < & < = 0 . 2 5 0 . 2 5 < & < = 0 . 5 0 . 5 < & < = 1 1 < & < = 2 2 < & < = 4 4 < & < = 8 8 < 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng A&H Soc 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 40% 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 Med Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng A&H Soc 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 40% 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 40% 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 40% 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 Med Life MPS Eng A&H Soc Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 45 Output by GERD Output and Open Access Impact by discipline Output by researcher Output and Open Access Output by discipline Papers per researcher (FTE) Papers per million GERD (PPP US$) GDP (PPP US$ billions) 2965.8 Patents 53,746 GERD (PPP US$ billions) 49.3 BERD (PPP US$ billions) 33.3 GERD/GDP (%) 1.66 Patents/BERD 1611.8 Open Access papers per year Open Access papers (inc G20) Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc Med Life MPS Eng A&D H&L Soc SAM 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc Med Life MPS Eng A&D H&L Soc SAM 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&D H&L AM Med Life MPS Eng A&D &L M 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 45 Output by GERD Output and Open Access Impact by discipline Output by researcher Output and Open Access Output by discipline Papers per researcher (FTE) Papers per million GERD (PPP US$) Domestic papers (inc G20) Category normalised citation impact Open Access papers per year Open Access papers (inc G20) Impact and collaboration Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM apers CNCI % > world average % in top 10% 274,025 1.41 41.1% 14.5% 550,634 1.10 35.0% 10.7% 723,391 1.65 45.6% 17.4% 164,121 0.99 31.3% 9.5% World average cites/paper = 1.0 < = 0 . 5 0 . 5 < & < = 1 1 < & < = 2 2 < & < = 4 4 < & < = 8 8 < < = 0 . 5 0 . 5 < & < = 1 1 < & < = 2 2 < & < = 4 4 < & < = 8 8 < 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 0.00 0.10 0.20 0.30 0.40 0.50 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc % 5% 0% 5% 00% 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng H oc Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc Eng A&D H&L Med Life MPS Eng A&D H&L Soc SAM 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc Med Life MPS Eng A&D H&L Soc SAM Med Life MPS Eng A&D H&L Soc SAM 0% 25% 50% 75% 100% 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc A&D Med Life MPS Eng A&D H&L Soc SAM 45 44 Output by GERD Output by researcher Papers per researcher (FTE) Papers per million GERD (PPP US$) Total and domestic papers per year Domestic papers (inc G20) Category normalised citation impact Open Access papers per year Open Access papers (inc G20) Output and collaboration Impact and collaboration Papers CNCI % > world average % in top 10% United Kingdom total 1,274,025 1.41 41.1% 14.5% United Kingdom domestic 550,634 1.10 35.0% 10.7% United Kingdom international 723,391 1.65 45.6% 17.4% G20 total dataset 15,164,121 0.99 31.3% 9.5% 0% U n c i t e d 0 < & < = 0 . 1 2 5 0 . 1 2 5 < & < = 0 . 2 5 0 . 2 5 < & < = 0 . 5 0 . 5 < & < = 1 1 < & < = 2 2 < & < = 4 4 < & < = 8 8 < U n c i t e d 0 < & < = 0 . 1 2 5 0 . 1 2 5 < & < = 0 . 2 5 0 . 2 5 < & < = 0 . 5 0 . 5 < & < = 1 1 < & < = 2 2 < & < = 4 4 < & < = 8 8 < 0% 10% 20% 30% 0 5,000 10,000 15,000 20,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Life MPS Eng A&H Soc 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc Eng A&D H&L 0% 10% 20% 30% 0 5,000 10,000 15,000 20,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Life MPS Eng A&H Soc 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc Life MPS Eng A&D H&L Soc SAM 0% 25% 50% 75% 100% 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc MPS Eng A&D H&L Soc 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc Eng A&D H&L 0% 25% 50% 75% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 0.00 0.50 1.00 1.50 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 0.00 0.10 0.20 0.30 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng A&H Soc Eng A&D H&L 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 Med Life MPS Eng A&H Soc Output trend is tracked over the last ten years Total paper count for the country The percentage of annual output that is still domestic Blue block is the count of domestic papers, with no international co-author G20 average percentage of annual output that is still domestic Trends in national OA output OA as a share of total output G20 average OA papers per year Country as a whole Papers with an international co-author G20 average CNCI Output and collaboration The citation impact of collaboration is shown by comparing average national impact with the papers that have an international co-author Impact and collaboration Impact by discipline Output by discipline Research productivity is analysed in terms of both output per unit GERD funding and output per researcher. Impact trend is tracked over the last ten years Research Footprints are supported by ‘spark lines’ showing ten-year trends by discipline group Each axis indicates the range of performance for a specific discipline group (see key) The maximum value on each axis is at the outer point and other values scale from there The dotted line shows the median value for the G20 The blue shape shows the Research Footprint for the country Research Footprints show how a research activity or performance measure varies across disciplines. They show the ‘footprint’ of the country on the global research landscape. The Research Footprints for publication output and for citation impact use eight major discipline groups (see key) within which there are broadly similar publication and citation patterns. Med = medicine Life = life sciences MPS = maths and physical sciences Eng = engineering and technology Soc = social sciences AH = arts and humanities AD = art and design HL = humanities and languages SAM = subjects allied to medicine ‘Open Access’ (OA) research publication, where the author or funder pays instead of the reader or a university library paying via journal subscription, is increasing in response to demands from research funders – including governments (see Global Research Report 2: The Plan S Footprint). The trends and patterns in OA research publication are shown in a graph and a Research Footprint. The Research Footprint uses only six axes because OA is still relatively scarce in humanities and social sciences. International collaboration in research has been growing and most of the world’s most highly-cited research now has authors from two or more countries. As a result, the specifically domestic part of each country’s research base has been shrinking and is contributing less to overall national impact (Adams, 2013). These graphs show the growth of collaboration and the contribution that it makes to average national citation impact. National performance G20 average papers per unit activity Output and Open Access Output and Open Access Average citation impact is shown relative to world average 8 Output by GERD Output and Open Access Impact by discipline Output by researcher Output and Open Access Output by discipline searcher (FTE) n GERD (PPP US$) United Kingdom Population 65,595,565 Researchers 510,980 Researchers / 1000 population 7.79 Female researchers 197,576 Women as % researchers 38.7 GDP (PPP US$ billions) 2965.8 Patents 53,746 GERD (PPP US$ billions) 49.3 BERD (PPP US$ billions) 33.3 GERD/GDP (%) 1.66 Patents/BERD 1611.8 ic papers per year Domestic paper sed citation impact Open Access papers per year Open Access papers (inc G20) Impact profile Output and collaboration Impact and collaboration Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM Papers CNCI % world average % in top 10% United Kingdom total 1,274,025 1.41 41.1% 14.5% United Kingdom domestic 550,634 1.10 35.0% 10.7% United Kingdom international 723,391 1.65 45.6% 17.4% G20 total dataset 15,164,121 0.99 31.3% 9.5% 0% 5% 10% 15% 20% 25% World average cites/paper = 1.0 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 50% 75% 100% 80,000 100,000 120,000 140,000 160,000 1.00 1.50 2.00 1.00 1.50 2.00 2.50 3.00 3.50 0.20 0.30 0.40 0.50 0.60 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 75% 100% 120,000 140,000 160,000 1.50 2.00 2.00 2.50 3.00 3.50 0.30 0.40 0.50 0.60 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 75% 100% 120,000 140,000 160,000 1.50 2.00 2.00 2.50 3.00 3.50 0.30 0.40 0.50 0.60 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 40% 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 50% 75% 100% 80,000 100,000 120,000 140,000 160,000 1.00 1.50 2.00 1.00 1.50 2.00 2.50 3.00 3.50 0.20 0.30 0.40 0.50 0.60 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM
  • 7. 11 10 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0.00 0.50 1.00 1.50 2.00 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc Output by GERD Output and Open Access Impact by discipline Output by researcher Output and Open Access Output by discipline Papers per researcher (FTE) Papers per million GERD (PPP US$) 0% 5% 10% 15% 20% 25% World average cites/paper = 1.0 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 Argentina Population 43,847,430 Researchers 83,947 Researchers / 1000 population 1.91 Female researchers 44,521 Women as % researchers 53.0 GDP (PPP US$ billions) 879.8 Patents 766 GERD (PPP US$ billions) 4.7 BERD (PPP US$ billions) 1.1 GERD/GDP (%) 0.53 Patents/BERD 684.7 Total and domestic papers per year Domestic papers (inc G20) Category normalised citation impact Open Access papers per year Open Access papers (inc G20) Impact profile Output and collaboration Impact and collaboration Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM Papers CNCI % world average % in top 10% Argentina total 98,448 0.92 25.8% 6.9% Argentina domestic 51,792 0.54 17.4% 2.9% Argentina international 46,656 1.34 35.1% 11.3% G20 total dataset 15,164,121 0.99 31.3% 9.5% 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0.00 0.50 1.00 1.50 2.00 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0.00 0.50 1.00 1.50 2.00 2.50 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0.00 0.50 1.00 1.50 2.00 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0.00 0.50 1.00 1.50 2.00 2.50 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0.00 0.50 1.00 1.50 2.00 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0.00 0.50 1.00 1.50 2.00 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0.00 0.50 1.00 1.50 2.00 2.50 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0.00 0.50 1.00 1.50 2.00 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0.00 0.50 1.00 1.50 2.00 2.50 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0.00 0.50 1.00 1.50 2.00 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 0 9 1 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 0.00 0.50 1.00 1.50 2.00 2.50 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0.00 0.50 1.00 1.50 2.00 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0.00 0.50 1.00 1.50 2.00 2.50 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0.00 0.50 1.00 1.50 2.00 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0.00 0.50 1.00 1.50 2.00 2.50 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AH Soc
  • 8. 13 12 Output by GERD Output and Open Access Impact by discipline Output by researcher Output and Open Access Output by discipline Papers per researcher (FTE) Papers per million GERD (PPP US$) 0% 5% 10% 15% 20% 25% World average cites/paper = 1.0 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 Australia Population 24,601,860 Researchers - Researchers / 1000 population - Female researchers - Women as % researchers 40% GDP (PPP US$ billions) 1099.9 Patents 11,656 GERD (PPP US$ billions) 21.2 BERD (PPP US$ billions) 11.3 GERD/GDP (%) 1.92 Patents/BERD 1031.4 Total and domestic papers per year Domestic papers (inc G20) Category normalised citation impact Open Access papers per year Open Access papers (inc G20) Impact profile Output and collaboration Impact and collaboration Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM Papers CNCI % world average % in top 10% Australia total 624,023 1.38 40.4% 14.0% Australia domestic 288,459 1.02 34.3% 9.8% Australia international 335,564 1.69 45.7% 17.5% G20 total dataset 15,164,121 0.99 31.3% 9.5% 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00 0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 0.80 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00 0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 0.80 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00 0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 0.80 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00 0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 0.80 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0 9 1 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00 0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 0.80 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00 0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 0.80 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00 0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 0.80 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM
  • 9. 15 14 Output by GERD Output and Open Access Impact by discipline Output by researcher Output and Open Access Output by discipline Papers per researcher (FTE) Papers per million GERD (PPP US$) 0% 5% 10% 15% 20% 25% World average cites/paper = 1.0 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 Brazil Population 209,288,278 Researchers - Researchers / 1000 population - Female researchers - Women as % researchers - GDP (PPP US$ billions) 3255.1 Patents 7,505 GERD (PPP US$ billions) - BERD (PPP US$ billions) - GERD/GDP (%) - Patents/BERD - Total and domestic papers per year Domestic papers (inc G20) Category normalised citation impact Open Access papers per year Open Access papers (inc G20) Impact profile Output and collaboration Impact and collaboration Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM Papers CNCI % world average % in top 10% Brazil total 463,357 0.79 23.3% 5.9% Brazil domestic 311,969 0.54 16.9% 3.1% Brazil international 151,388 1.30 36.6% 11.9% G20 total dataset 15,164,121 0.99 31.3% 9.5% 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0 9 1 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM
  • 10. 17 16 Output by GERD Output and Open Access Impact by discipline Output by researcher Output and Open Access Output by discipline Papers per researcher (FTE) Papers per million GERD (PPP US$) 0% 5% 10% 15% 20% 25% World average cites/paper = 1.0 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 Canada Population 36,708,083 Researchers - Researchers / 1000 population - Female researchers - Women as % researchers - GDP (PPP US$ billions) 1707.3 Patents 23,914 GERD (PPP US$ billions) 27.2 BERD (PPP US$ billions) 14.1 GERD/GDP (%) 1.59 Patents/BERD 1700.9 Total and domestic papers per year Domestic papers (inc G20) Category normalised citation impact Open Access papers per year Open Access papers (inc G20) Impact profile Output and collaboration Impact and collaboration Papers CNCI % world average % in top 10% Canada total 736,856 1.31 38.2% 12.8% Canada domestic 352,119 0.95 31.8% 8.6% Canada international 384,737 1.64 44.1% 16.6% G20 total dataset 15,164,121 0.99 31.3% 9.5% Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0 9 1 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM
  • 11. 19 18 Output by GERD Output and Open Access Impact by discipline Output by researcher Output and Open Access Output by discipline Papers per researcher (FTE) Papers per million GERD (PPP US$) 0% 5% 10% 15% 20% 25% World average cites/paper = 1.0 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 China Population 1,350,695,000 Researchers 2,069,650 Researchers / 1000 population 1.53 Female researchers - Women as % researchers - GDP (PPP US$ billions) 23350.2 Patents 1,306,019 GERD (PPP US$ billions) 496.0 BERD (PPP US$ billions) 384.8 GERD/GDP (%) 2.12 Patents/BERD 3393.8 Total and domestic papers per year Domestic papers (inc G20) Category normalised citation impact Open Access papers per year Open Access papers (inc G20) Impact profile Output and collaboration Impact and collaboration Papers CNCI % world average % in top 10% China total 2,741,465 1.01 31.1% 10.1% China domestic 2,039,968 0.86 27.6% 8.3% China international 701,497 1.44 41.2% 15.4% G20 total dataset 15,164,121 0.99 31.3% 9.5% Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 50,000 100,000 150,000 200,000 250,000 300,000 350,000 400,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 50,000 100,000 150,000 200,000 250,000 300,000 350,000 400,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 50,000 100,000 150,000 200,000 250,000 300,000 350,000 400,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 50,000 100,000 150,000 200,000 250,000 300,000 350,000 400,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 50,000 100,000 150,000 200,000 250,000 300,000 350,000 400,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0 9 1 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 50,000 100,000 150,000 200,000 250,000 300,000 350,000 400,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 50,000 100,000 150,000 200,000 250,000 300,000 350,000 400,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 50,000 100,000 150,000 200,000 250,000 300,000 350,000 400,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM
  • 12. 21 20 Output by GERD Output and Open Access Impact by discipline Output by researcher Output and Open Access Output by discipline Papers per researcher (FTE) Papers per million GERD (PPP US$) 0% 5% 10% 15% 20% 25% World average cites/paper = 1.0 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 France Population 66,593,366 Researchers 383,843 Researchers / 1000 population 5.76 Female researchers 103,521 Women as % researchers 27.0 GDP (PPP US$ billions) 2954.9 Patents 70,939 GERD (PPP US$ billions) 64.7 BERD (PPP US$ billions) 42.0 GERD/GDP (%) 2.19 Patents/BERD 1688.8 Total and domestic papers per year Domestic papers (inc G20) Category normalised citation impact Open Access papers per year Open Access papers (inc G20) Impact profile Output and collaboration Impact and collaboration Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM Papers CNCI % world average % in top 10% France total 818,118 1.22 36.0% 11.9% France domestic 351,729 0.83 27.8% 7.5% France international 466,389 1.50 42.2% 15.2% G20 total dataset 15,164,121 0.99 31.3% 9.5% 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0 9 1 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM
  • 13. 23 22 Output by GERD Output and Open Access Impact by discipline Output by researcher Output and Open Access Output by discipline Papers per researcher (FTE) Papers per million GERD (PPP US$) 0% 5% 10% 15% 20% 25% World average cites/paper = 1.0 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 Germany Population 81,686,611 Researchers 586,030 Researchers / 1000 population 7.17 Female researchers 164,095 Women as % researchers 28.0 GDP (PPP US$ billions) 4345.6 Patents 176,235 GERD (PPP US$ billions) 131.3 BERD (PPP US$ billions) 91.0 GERD/GDP (%) 3.02 Patents/BERD 1936.2 Total and domestic papers per year Domestic papers (inc G20) Category normalised citation impact Open Access papers per year Open Access papers (inc G20) Impact profile Output and collaboration Impact and collaboration Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM Papers CNCI % world average % in top 10% Germany total 1,172,143 1.25 37.4% 12.6% Germany domestic 534,443 0.90 29.5% 8.3% Germany international 637,700 1.54 44.0% 16.2% G20 total dataset 15,164,121 0.99 31.3% 9.5% 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0 9 1 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM
  • 14. 25 24 Output by GERD Output and Open Access Impact by discipline Output by researcher Output and Open Access Output by discipline Papers per researcher (FTE) Papers per million GERD (PPP US$) 0% 5% 10% 15% 20% 25% World average cites/paper = 1.0 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 India Population 1,339,180,127 Researchers - Researchers / 1000 population - Female researchers - Women as % researchers - GDP (PPP US$ billions) 9596.8 Patents 27,985 GERD (PPP US$ billions) - BERD (PPP US$ billions) - GERD/GDP (%) - Patents/BERD - Total and domestic papers per year Domestic papers (inc G20) Category normalised citation impact Open Access papers per year Open Access papers (inc G20) Impact profile Output and collaboration Impact and collaboration Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM Papers CNCI % world average % in top 10% India total 633,300 0.79 24.2% 6.6% India domestic 481,840 0.64 20.8% 5.0% India international 151,460 1.26 35.1% 11.9% G20 total dataset 15,164,121 0.99 31.3% 9.5% 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 1,000 2,000 3,000 4,000 5,000 6,000 7,000 8,000 9,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 1,000 2,000 3,000 4,000 5,000 6,000 7,000 8,000 9,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 1,000 2,000 3,000 4,000 5,000 6,000 7,000 8,000 9,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 1,000 2,000 3,000 4,000 5,000 6,000 7,000 8,000 9,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 1,000 2,000 3,000 4,000 5,000 6,000 7,000 8,000 9,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0 9 1 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM
  • 15. 27 26 Output by GERD Output and Open Access Impact by discipline Output by researcher Output and Open Access Output by discipline Papers per researcher (FTE) Papers per million GERD (PPP US$) 0% 5% 10% 15% 20% 25% 30% 35% 40% 45% World average cites/paper = 1.0 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 Indonesia Population 263,991,379 Researchers - Researchers / 1000 population - Female researchers - Women as % researchers - GDP (PPP US$ billions) 3249.6 Patents 2,320 GERD (PPP US$ billions) - BERD (PPP US$ billions) - GERD/GDP (%) - Patents/BERD - Total and domestic papers per year Domestic papers (inc G20) Category normalised citation impact Open Access papers per year Open Access papers (inc G20) Impact profile Output and collaboration Impact and collaboration Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM Papers CNCI % world average % in top 10% Indonesia total 20,828 1.05 28.3% 8.1% Indonesia domestic 3,838 0.44 13.3% 2.7% Indonesia international 16,990 1.18 31.7% 9.4% G20 total dataset 15,164,121 0.99 31.3% 9.5% 0% 25% 50% 75% 100% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 100 200 300 400 500 600 700 800 900 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 100 200 300 400 500 600 700 800 900 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 100 200 300 400 500 600 700 800 900 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 100 200 300 400 500 600 700 800 900 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 100 200 300 400 500 600 700 800 900 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0 9 1 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM
  • 16. 29 28 Output by GERD Output and Open Access Impact by discipline Output by researcher Output and Open Access Output by discipline Papers per researcher (FTE) Papers per million GERD (PPP US$) 0% 5% 10% 15% 20% 25% World average cites/paper = 1.0 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 Italy Population 60,627,498 Researchers 185,916 Researchers / 1000 population 3.07 Female researchers 65,431 Women as % researchers 35.2 GDP (PPP US$ billions) 2477.4 Patents 31,346 GERD (PPP US$ billions) 33.5 BERD (PPP US$ billions) 20.6 GERD/GDP (%) 1.35 Patents/BERD 1521.3 Total and domestic papers per year Domestic papers (inc G20) Category normalised citation impact Open Access papers per year Open Access papers (inc G20) Impact profile Output and collaboration Impact and collaboration Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM Papers CNCI % world average % in top 10% Italy total 713,369 1.24 37.5% 12.1% Italy domestic 364,725 0.88 30.3% 7.7% Italy international 348,644 1.61 45.1% 16.6% G20 total dataset 15,164,121 0.99 31.3% 9.5% 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 0.00 0.50 1.00 1.50 2.00 2.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 0.00 0.50 1.00 1.50 2.00 2.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 0.00 0.50 1.00 1.50 2.00 2.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0 9 1 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM
  • 17. 31 30 Output by GERD Output and Open Access Impact by discipline Output by researcher Output and Open Access Output by discipline Papers per researcher (FTE) Papers per million GERD (PPP US$) 0% 5% 10% 15% 20% 25% World average cites/paper = 1.0 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 Japan Population 126,785,797 Researchers 930,720 Researchers / 1000 population 7.34 Female researchers 150,545 Women as % researchers 16.2 GDP (PPP US$ billions) 5333.4 Patents 460,660 GERD (PPP US$ billions) 170.9 BERD (PPP US$ billions) 134.7 GERD/GDP (%) 3.20 Patents/BERD 3420.9 Total and domestic papers per year Domestic papers (inc G20) Category normalised citation impact Open Access papers per year Open Access papers (inc G20) Impact profile Output and collaboration Impact and collaboration Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM Papers CNCI % world average % in top 10% Japan total 899,903 0.87 25.6% 7.1% Japan domestic 629,161 0.66 20.6% 4.6% Japan international 270,742 1.34 37.1% 12.8% G20 total dataset 15,164,121 0.99 31.3% 9.5% 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 80,000 90,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0 9 1 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM
  • 18. 33 32 Output by GERD Output and Open Access Impact by discipline Output by researcher Output and Open Access Output by discipline Papers per researcher (FTE) Papers per million GERD (PPP US$) 0% 5% 10% 15% 20% 25% 30% World average cites/paper = 1.0 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 Mexico Population 122,535,969 Researchers 42,222 Researchers / 1000 population 0.34 Female researchers 13,943 Women as % researchers 33.0 GDP (PPP US$ billions) 2316.3 Patents 2,522 GERD (PPP US$ billions) 11.3 BERD (PPP US$ billions) 3.4 GERD/GDP (%) 0.49 Patents/BERD 733.0 Total and domestic papers per year Domestic papers (inc G20) Category normalised citation impact Open Access papers per year Open Access papers (inc G20) Impact profile Output and collaboration Impact and collaboration Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM Papers CNCI % world average % in top 10% Mexico total 143,215 0.81 22.3% 6.0% Mexico domestic 77,951 0.46 13.8% 2.4% Mexico international 65,264 1.23 32.5% 10.4% G20 total dataset 15,164,121 0.99 31.3% 9.5% 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 20,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 4,500 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 20,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 20,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 4,500 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 20,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 20,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 4,500 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 20,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 4,500 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 20,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 20,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 4,500 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0 9 1 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM
  • 19. 35 34 Output by GERD Output and Open Access Impact by discipline Output by researcher Output and Open Access Output by discipline Papers per researcher (FTE) Papers per million GERD (PPP US$) 0% 5% 10% 15% 20% 25% 30% 35% 40% World average cites/paper = 1.0 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 Russia Population 144,496,740 Researchers 359,793 Researchers / 1000 population 2.49 Female researchers 142,290 Women as % researchers 39.5 GDP (PPP US$ billions) 3783.1 Patents 27,782 GERD (PPP US$ billions) 41.9 BERD (PPP US$ billions) 25.2 GERD/GDP (%) 1.11 Patents/BERD 1103.3 Total and domestic papers per year Domestic papers (inc G20) Category normalised citation impact Open Access papers per year Open Access papers (inc G20) Impact profile Output and collaboration Impact and collaboration Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM Papers CNCI % world average % in top 10% Russia total 366,639 0.59 15.5% 4.2% Russia domestic 237,990 0.28 7.1% 1.2% Russia international 128,649 1.18 31.2% 9.9% G20 total dataset 15,164,121 0.99 31.3% 9.5% 0% 25% 50% 75% 100% 0 5,000 10,000 15,000 20,000 25,000 30,000 35,000 40,000 45,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 4,500 5,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 5,000 10,000 15,000 20,000 25,000 30,000 35,000 40,000 45,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 5,000 10,000 15,000 20,000 25,000 30,000 35,000 40,000 45,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 4,500 5,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 5,000 10,000 15,000 20,000 25,000 30,000 35,000 40,000 45,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 5,000 10,000 15,000 20,000 25,000 30,000 35,000 40,000 45,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 4,500 5,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 5,000 10,000 15,000 20,000 25,000 30,000 35,000 40,000 45,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 4,500 5,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 5,000 10,000 15,000 20,000 25,000 30,000 35,000 40,000 45,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 5,000 10,000 15,000 20,000 25,000 30,000 35,000 40,000 45,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 4,500 5,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0 9 1 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM
  • 20. 37 36 Output by GERD Output and Open Access Impact by discipline Output by researcher Output and Open Access Output by discipline Papers per researcher (FTE) Papers per million GERD (PPP US$) 0% 5% 10% 15% 20% 25% 30% World average cites/paper = 1.0 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 8 Saudi Arabia Population 32,938,213 Researchers - Researchers / 1000 population - Female researchers - Women as % researchers - GDP (PPP US$ billions) 1775.1 Patents 4,405 GERD (PPP US$ billions) - BERD (PPP US$ billions) - GERD/GDP (%) - Patents/BERD - Total and domestic papers per year Domestic papers (inc G20) Category normalised citation impact Open Access papers per year Open Access papers (inc G20) Impact profile Output and collaboration Impact and collaboration Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM Papers CNCI % world average % in top 10% Saudi Arabia total 109,417 1.27 33.1% 12.7% Saudi Arabia domestic 24,217 0.66 20.2% 5.6% Saudi Arabia international 85,200 1.45 36.8% 14.7% G20 total dataset 15,164,121 0.99 31.3% 9.5% 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0 9 1 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM
  • 21. 39 38 Output by GERD Output and Open Access Impact by discipline Output by researcher Output and Open Access Output by discipline Papers per researcher (FTE) Papers per million GERD (PPP US$) 0% 5% 10% 15% 20% 25% 30% World average cites/paper = 1.0 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 8 South Africa Population 55,291,225 Researchers 51,877 Researchers / 1000 population 0.94 Female researchers 23,334 Women as % researchers 45.0 GDP (PPP US$ billions) 730.9 Patents 2,178 GERD (PPP US$ billions) 5.8 BERD (PPP US$ billions) 2.5 GERD/GDP (%) 0.80 Patents/BERD 876.4 Total and domestic papers per year Domestic papers (inc G20) Category normalised citation impact Open Access papers per year Open Access papers (inc G20) Impact profile Output and collaboration Impact and collaboration Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM Papers CNCI % world average % in top 10% South Africa total 130,175 1.10 30.4% 9.5% South Africa domestic 57,665 0.59 19.3% 3.8% South Africa international 72,510 1.50 39.3% 14.1% G20 total dataset 15,164,121 0.99 31.3% 9.5% 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 18,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 0.00 0.10 0.20 0.30 0.40 0.50 0.60 0.70 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0 9 1 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM
  • 22. 41 40 Output by GERD Output and Open Access Impact by discipline Output by researcher Output and Open Access Output by discipline Papers per researcher (FTE) Papers per million GERD (PPP US$) 0% 5% 10% 15% 20% 25% World average cites/paper = 1.0 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 South Korea Population 51,466,201 Researchers 482,796 Researchers / 1000 population 9.38 Female researchers 97,042 Women as % researchers 20.1 GDP (PPP US$ billions) 1998.1 Patents 226,568 GERD (PPP US$ billions) 91.0 BERD (PPP US$ billions) 72.2 GERD/GDP (%) 4.55 Patents/BERD 3136.2 Total and domestic papers per year Domestic papers (inc G20) Category normalised citation impact Open Access papers per year Open Access papers (inc G20) Impact profile Output and collaboration Impact and collaboration Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM Papers CNCI % world average % in top 10% South Korea total 582,754 0.88 26.3% 7.6% South Korea domestic 410,239 0.68 22.1% 5.3% South Korea international 172,515 1.34 36.4% 12.9% G20 total dataset 15,164,121 0.99 31.3% 9.5% 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 2,000 4,000 6,000 8,000 10,000 12,000 14,000 16,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0 9 1 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM
  • 23. 43 42 Output by GERD Output and Open Access Impact by discipline Output by researcher Output and Open Access Output by discipline Papers per researcher (FTE) Papers per million GERD (PPP US$) 0% 5% 10% 15% 20% 25% 30% World average cites/paper = 1.0 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 8 Turkey Population 80,745,020 Researchers 210,769 Researchers / 1000 population 2.61 Female researchers 78,056 Women as % researchers 37.0 GDP (PPP US$ billions) 2261.0 Patents 11,144 GERD (PPP US$ billions) 21.7 BERD (PPP US$ billions) 12.4 GERD/GDP (%) 0.96 Patents/BERD 901.7 Total and domestic papers per year Domestic papers (inc G20) Category normalised citation impact Open Access papers per year Open Access papers (inc G20) Impact profile Output and collaboration Impact and collaboration Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM Papers CNCI % world average % in top 10% Turkey total 300,883 0.67 19.7% 5.2% Turkey domestic 235,602 0.50 15.3% 3.2% Turkey international 65,281 1.31 35.7% 12.6% G20 total dataset 15,164,121 0.99 31.3% 9.5% 0% 25% 50% 75% 100% 0 5,000 10,000 15,000 20,000 25,000 30,000 35,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 4,500 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 5,000 10,000 15,000 20,000 25,000 30,000 35,000 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 0.45 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 5,000 10,000 15,000 20,000 25,000 30,000 35,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 4,500 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 5,000 10,000 15,000 20,000 25,000 30,000 35,000 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 0.45 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 0.45 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 5,000 10,000 15,000 20,000 25,000 30,000 35,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 4,500 0.00 0.50 1.00 1.50 2.00 2.50 3.00 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 0.45 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 5,000 10,000 15,000 20,000 25,000 30,000 35,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 4,500 0.00 0.50 1.00 1.50 2.00 2.50 3.00 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 0.45 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 5,000 10,000 15,000 20,000 25,000 30,000 35,000 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 0.45 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 5,000 10,000 15,000 20,000 25,000 30,000 35,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 500 1,000 1,500 2,000 2,500 3,000 3,500 4,000 4,500 0.00 0.50 1.00 1.50 2.00 2.50 3.00 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 0.45 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0 9 1 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM
  • 24. 45 44 Output by GERD Output and Open Access Impact by discipline Output by researcher Output and Open Access Output by discipline Papers per researcher (FTE) Papers per million GERD (PPP US$) United Kingdom Population 65,595,565 Researchers 510,980 Researchers / 1000 population 7.79 Female researchers 197,576 Women as % researchers 38.7 GDP (PPP US$ billions) 2965.8 Patents 53,746 GERD (PPP US$ billions) 49.3 BERD (PPP US$ billions) 33.3 GERD/GDP (%) 1.66 Patents/BERD 1611.8 Total and domestic papers per year Domestic papers (inc G20) Category normalised citation impact Open Access papers per year Open Access papers (inc G20) Impact profile Output and collaboration Impact and collaboration Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM Papers CNCI % world average % in top 10% United Kingdom total 1,274,025 1.41 41.1% 14.5% United Kingdom domestic 550,634 1.10 35.0% 10.7% United Kingdom international 723,391 1.65 45.6% 17.4% G20 total dataset 15,164,121 0.99 31.3% 9.5% 0% 5% 10% 15% 20% 25% World average cites/paper = 1.0 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 20,000 40,000 60,000 80,000 100,000 120,000 140,000 160,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 5,000 10,000 15,000 20,000 25,000 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 0.00 0.10 0.20 0.30 0.40 0.50 0.60 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0 9 1 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM
  • 25. 47 46 Output by GERD Output and Open Access Impact by discipline Output by researcher Output and Open Access Output by discipline Papers per researcher (FTE) Papers per million GERD (PPP US$) 0% 5% 10% 15% 20% 25% World average cites/paper = 1.0 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 U n c i t e d 0 = 0 . 1 2 5 0 . 1 2 5 = 0 . 2 5 0 . 2 5 = 0 . 5 0 . 5 = 1 1 = 2 2 = 4 4 = 8 8 United States Population 325,147,121 Researchers - Researchers / 1000 population - Female researchers - Women as % researchers - GDP (PPP US$ billions) 19485.4 Patents 524,835 GERD (PPP US$ billions) 543.2 BERD (PPP US$ billions) 397.1 GERD/GDP (%) 2.79 Patents/BERD 1321.8 Total and domestic papers per year Domestic papers (inc G20) Category normalised citation impact Open Access papers per year Open Access papers (inc G20) Impact profile Output and collaboration Impact and collaboration Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM Papers CNCI % world average % in top 10% United States total 4,427,597 1.31 39.2% 13.5% United States domestic 2,819,840 1.17 36.4% 11.7% United States international 1,607,757 1.55 44.0% 16.5% G20 total dataset 15,164,121 0.99 31.3% 9.5% 0% 25% 50% 75% 100% 0 50,000 100,000 150,000 200,000 250,000 300,000 350,000 400,000 450,000 500,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 50,000 100,000 150,000 200,000 250,000 300,000 350,000 400,000 450,000 500,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 50,000 100,000 150,000 200,000 250,000 300,000 350,000 400,000 450,000 500,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 Med Life MPS Eng AH Soc 0% 25% 50% 75% 100% 0 50,000 100,000 150,000 200,000 250,000 300,000 350,000 400,000 450,000 500,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 50,000 100,000 150,000 200,000 250,000 300,000 350,000 400,000 450,000 500,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 50,000 100,000 150,000 200,000 250,000 300,000 350,000 400,000 450,000 500,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 50,000 100,000 150,000 200,000 250,000 300,000 350,000 400,000 450,000 500,000 0.00 0.50 1.00 1.50 2.00 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 Med Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM 0% 25% 50% 75% 100% 0 50,000 100,000 150,000 200,000 250,000 300,000 350,000 400,000 450,000 500,000 0.00 0.50 1.00 1.50 2.00 0% 10% 20% 30% 40% 0 10,000 20,000 30,000 40,000 50,000 60,000 70,000 0.00 0.20 0.40 0.60 0.80 1.00 1.20 1.40 1.60 1.80 0.00 0.05 0.10 0.15 0.20 0.25 0.30 0.35 0.40 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 2 0 1 8 0 9 1 0 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 2 0 0 9 2 0 1 0 2 0 1 1 2 0 1 2 2 0 1 3 2 0 1 4 2 0 1 5 2 0 1 6 2 0 1 7 Med Life MPS Eng AH Soc Life MPS Eng AD HL Soc SAM Med Life MPS Eng AD HL Soc SAM
  • 26. 48 About the Global Research Report series from the Institute for Scientific Information (ISI) Global Research Reports is a new publication series from ISI which aims to inform and stimulate debate at the highest levels. The reports demonstrate the huge potential of research data to inform management issues in research assessment and research policy, and to accelerate development of the global research base. Previous reports include: GRR 1 - Profiles not metrics, January 2019 GRR 2 - The Plan S Footprint: Implications for the Scholarly Publishing Landscape, February 2019 GRR 3 – Navigating the Structure of Research on Sustainable Development Goals, April 2019 If you would like to sign up to receive our future reports or would like to find out more about the work of the Institute for Scientific Information, please do get in touch via email. We look forward to hearing from you. e: isi@clarivate.com Sign up to receive reports here: www.webofsciencegroup.com References 2013. Adams J. The fourth age of research. Nature, 497, 557-560. 2007. Adams J, Gurney K A and Marshall S. Profiling citation impact: a new methodology. Scientometrics, 72 (2), 325-344.
  • 27. Contact our experts today: webofsciencegroup.com © 2019 Clarivate Analytics. Web of Science Group and its logo, as well as all other trademarks used herein are trademarks of their respective owners and used under license.